CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | EC 5.3.* (intramolecular oxidoreductase) inhibitor |
|
Accession: | CHEBI:76694
|
browse the term
|
Definition: | An isomerase inhibitor that interferes with the action of an intramolecular oxidoreductase (EC 5.3.*.*). |
Synonyms: | related_synonym: | intramolecular oxidoreductase (EC 5.3.*) inhibitors; intramolecular oxidoreductase inhibitor; intramolecular oxidoreductase inhibitors |
|
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
multiple interactions |
ISO |
amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of CCL5 mRNA] |
CTD |
PMID:23688403 |
|
NCBI chr10:68,322,826...68,327,365
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
multiple interactions |
ISO |
amorolfine inhibits the reaction [Biological Products results in increased expression of CXCL10 mRNA]; amorolfine inhibits the reaction [Biological Products results in increased expression of CXCL10 protein] |
CTD |
PMID:24471457 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Il4 |
interleukin 4 |
multiple interactions |
ISO |
4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-(4-(2H-tetrazol-5-yl)butyl)piperidine inhibits the reaction [amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in decreased secretion of 15-deoxy-delta(12,14)-prostaglandin J2]]; 4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-(4-(2H-tetrazol-5-yl)butyl)piperidine inhibits the reaction [amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in decreased secretion of Prostaglandin D2]]; 4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-(4-(2H-tetrazol-5-yl)butyl)piperidine inhibits the reaction [amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of TSLP mRNA]]; 4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-(4-(2H-tetrazol-5-yl)butyl)piperidine inhibits the reaction [amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of TSLP protein]]; amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in decreased secretion of 15-deoxy-delta(12,14)-prostaglandin J2]; amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in decreased secretion of Prostaglandin D2]; amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased degradation of NFKBIA protein]; amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of CCL5 mRNA]; amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of CXCL8 mRNA]; amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of TSLP mRNA]; amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of TSLP protein]; amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased secretion of Thromboxane B2]; amorolfine promotes the reaction [[Poly I-C co-treated with IL4 protein] results in increased secretion of Dinoprostone] |
CTD |
PMID:23688403 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
decreases activity |
ISO |
amorolfine results in decreased activity of KCNH2 protein |
CTD |
PMID:28551711 |
|
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased degradation of NFKBIA protein] |
CTD |
PMID:23688403 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
multiple interactions |
ISO |
amorolfine inhibits the reaction [Biological Products results in increased phosphorylation of and results in increased activity of STAT1 protein] |
CTD |
PMID:24471457 |
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Tslp |
thymic stromal lymphopoietin |
multiple interactions |
ISO |
4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-(4-(2H-tetrazol-5-yl)butyl)piperidine inhibits the reaction [amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of TSLP mRNA]]; 4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-(4-(2H-tetrazol-5-yl)butyl)piperidine inhibits the reaction [amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of TSLP protein]]; amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of TSLP mRNA]; amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of TSLP protein] |
CTD |
PMID:23688403 |
|
NCBI chr18:24,447,409...24,454,244
Ensembl chr18:24,449,844...24,453,548
|
|
|
G |
Aasdhppt |
aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase |
decreases expression |
ISO |
cupric chloride results in decreased expression of AASDHPPT mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 8:1,453,226...1,463,990
Ensembl chr 8:1,452,282...1,463,966
|
|
G |
Abcf3 |
ATP binding cassette subfamily F member 3 |
increases expression |
ISO |
cupric chloride results in increased expression of ABCF3 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr11:80,340,476...80,352,211
Ensembl chr11:80,339,977...80,352,211
|
|
G |
Abhd4 |
abhydrolase domain containing 4, N-acyl phospholipase B |
increases expression |
ISO |
cupric chloride results in increased expression of ABHD4 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr15:27,697,384...27,716,013
Ensembl chr15:27,704,113...27,716,966
|
|
G |
Acat2 |
acetyl-CoA acetyltransferase 2 |
decreases expression |
ISO |
cupric chloride results in decreased expression of ACAT2 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr 1:47,695,833...47,713,879
Ensembl chr 1:47,695,788...47,752,821
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions decreases activity |
EXP ISO |
cupric chloride inhibits the reaction [Mercuric Chloride results in decreased activity of ACHE protein] cupric chloride results in decreased activity of ACHE protein Carnosine inhibits the reaction [cupric chloride results in decreased activity of ACHE protein] |
CTD |
PMID:24799335 PMID:32745495 |
|
NCBI chr12:19,407,359...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Aco1 |
aconitase 1 |
decreases expression |
ISO |
cupric chloride results in decreased expression of ACO1 protein |
CTD |
PMID:29617964 |
|
NCBI chr 5:55,259,841...55,315,872
Ensembl chr 5:55,259,827...55,316,391
|
|
G |
Acss2 |
acyl-CoA synthetase short-chain family member 2 |
decreases expression |
ISO |
cupric chloride results in decreased expression of ACSS2 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675
|
|
G |
Actb |
actin, beta |
increases expression |
ISO |
cupric chloride results in increased expression of ACTB protein |
CTD |
PMID:29617964 |
|
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
|
|
G |
Adrm1 |
ADRM1 26S proteasome ubiquitin receptor |
increases expression |
ISO |
cupric chloride results in increased expression of ADRM1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 3:167,265,435...167,270,197
Ensembl chr 3:167,265,296...167,270,195
|
|
G |
Ahsg |
alpha-2-HS-glycoprotein |
decreases expression |
ISO |
cupric chloride results in decreased expression of AHSG mRNA |
CTD |
PMID:17211630 |
|
NCBI chr11:78,117,903...78,145,956
Ensembl chr11:78,117,918...78,145,999
|
|
G |
Akr1a1 |
aldo-keto reductase family 1 member A1 |
increases expression |
ISO |
cupric chloride results in increased expression of AKR1A1 protein |
CTD |
PMID:29617964 |
|
NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674
|
|
G |
Alb |
albumin |
multiple interactions |
ISO |
ALB protein inhibits the reaction [cupric chloride results in decreased activity of PROC protein] |
CTD |
PMID:11820775 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh1l1 |
aldehyde dehydrogenase 1 family, member L1 |
increases expression |
ISO |
cupric chloride results in increased expression of ALDH1L1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 4:123,059,989...123,106,471
Ensembl chr 4:123,060,008...123,106,465
|
|
G |
Aldoa |
aldolase, fructose-bisphosphate A |
increases expression |
ISO |
cupric chloride results in increased expression of ALDOA mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
|
|
G |
Aldoc |
aldolase, fructose-bisphosphate C |
decreases expression |
ISO |
cupric chloride results in decreased expression of ALDOC protein |
CTD |
PMID:29617964 |
|
NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066
|
|
G |
Alkbh2 |
alkB homolog 2, alpha-ketoglutarate-dependent dioxygenase |
decreases activity |
ISO |
cupric chloride results in decreased activity of ALKBH2 protein |
CTD |
PMID:28926697 |
|
NCBI chr12:42,494,187...42,500,929
Ensembl chr12:42,496,300...42,500,914
|
|
G |
Alkbh3 |
alkB homolog 3, alpha-ketoglutarate-dependent dioxygenase |
decreases activity |
ISO |
cupric chloride results in decreased activity of ALKBH3 protein |
CTD |
PMID:28926697 |
|
NCBI chr 3:79,939,515...79,972,820
Ensembl chr 3:79,939,600...79,972,000
|
|
G |
Ankrd1 |
ankyrin repeat domain 1 |
increases expression |
ISO |
cupric chloride results in increased expression of ANKRD1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:233,815,851...233,834,919
|
|
G |
Anpep |
alanyl aminopeptidase, membrane |
decreases expression |
ISO |
cupric chloride results in decreased expression of ANPEP mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:133,767,332...133,810,137
Ensembl chr 1:133,767,332...133,785,789
|
|
G |
Apom |
apolipoprotein M |
increases expression |
ISO |
cupric chloride results in increased expression of APOM mRNA |
CTD |
PMID:17211630 |
|
NCBI chr20:3,690,950...3,693,550
Ensembl chr20:3,688,413...3,693,550
|
|
G |
App |
amyloid beta precursor protein |
increases expression multiple interactions |
EXP ISO |
cupric chloride results in increased expression of APP mRNA; cupric chloride results in increased expression of APP protein cupric chloride results in decreased uptake of and results in decreased degradation of APP protein modified form; PP242 inhibits the reaction [cupric chloride results in decreased uptake of and results in decreased degradation of APP protein modified form] |
CTD |
PMID:22542740 PMID:32512069 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
[Disulfiram co-treated with cupric chloride] results in decreased expression of AR protein |
CTD |
PMID:19789329 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Atf2 |
activating transcription factor 2 |
multiple interactions |
ISO |
[[cupric chloride results in increased abundance of Copper] co-treated with [zinc chloride results in increased abundance of Zinc]] results in increased phosphorylation of ATF2 protein; pyrazolanthrone inhibits the reaction [[[cupric chloride results in increased abundance of Copper] co-treated with [zinc chloride results in increased abundance of Zinc]] results in increased phosphorylation of ATF2 protein] |
CTD |
PMID:30768131 |
|
NCBI chr 3:58,718,323...58,795,280
Ensembl chr 3:58,718,332...58,795,236
|
|
G |
Atf4 |
activating transcription factor 4 |
multiple interactions |
EXP |
[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased expression of ATF4 mRNA; pyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased expression of ATF4 mRNA] |
CTD |
PMID:20920558 |
|
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Atm |
ATM serine/threonine kinase |
multiple interactions |
ISO |
cupric chloride results in increased phosphorylation of and results in increased activity of ATM protein |
CTD |
PMID:16959548 |
|
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Atox1 |
antioxidant 1 copper chaperone |
multiple interactions |
ISO |
[cupric chloride results in increased abundance of Copper] which results in increased expression of ATOX1 mRNA; ATOX1 protein results in decreased susceptibility to [cupric chloride results in increased abundance of Copper] |
CTD |
PMID:32278528 |
|
NCBI chr10:39,564,855...39,579,892
Ensembl chr10:39,564,857...39,579,950
|
|
G |
Atp7a |
ATPase copper transporting alpha |
increases transport increases expression multiple interactions decreases glutathionylation affects localization |
ISO EXP |
ATP7A protein results in increased transport of cupric chloride cupric chloride results in increased expression of ATP7A protein cupric chloride inhibits the reaction [Cycloheximide results in decreased expression of ATP7A protein]; cupric chloride promotes the reaction [Deferoxamine results in increased expression of ATP7A mRNA]; Deferoxamine promotes the reaction [cupric chloride results in increased expression of ATP7A protein] cupric chloride results in decreased glutathionylation of ATP7A protein cupric chloride affects the localization of ATP7A protein Omeprazole inhibits the reaction [cupric chloride affects the localization of ATP7A protein] ATP7A protein results in decreased susceptibility to [cupric chloride results in increased abundance of Copper]; ATP7A protein results in decreased uptake of [cupric chloride results in increased abundance of Copper]; cupric chloride inhibits the reaction [bathocuproine sulfonate inhibits the reaction [ATP7A protein results in increased activity of TYR protein]]; cupric chloride promotes the reaction [CLU protein binds to ATP7A protein] |
CTD |
PMID:11092760 PMID:16317117 PMID:17009961 PMID:20566629 PMID:21242307 PMID:23174565 PMID:25337692 PMID:32278528 More...
|
|
NCBI chr X:71,094,144...71,201,550
Ensembl chr X:71,094,202...71,198,354
|
|
G |
Atp7b |
ATPase copper transporting beta |
decreases response to substance affects localization multiple interactions |
ISO EXP |
ATP7B protein results in decreased susceptibility to cupric chloride cupric chloride affects the localization of ATP7B protein ATP7B protein results in decreased susceptibility to [cupric chloride results in increased abundance of Copper]; ATP7B protein results in increased uptake of [cupric chloride results in increased abundance of Copper]; cupric chloride promotes the reaction [CLU protein binds to ATP7B protein] |
CTD |
PMID:10728692 PMID:16799059 PMID:21242307 PMID:24343273 PMID:32278528 |
|
NCBI chr16:69,952,286...70,024,404
Ensembl chr16:69,951,778...70,023,636
|
|
G |
Bace1 |
beta-secretase 1 |
increases expression |
EXP |
cupric chloride results in increased expression of BACE1 mRNA; cupric chloride results in increased expression of BACE1 protein |
CTD |
PMID:22542740 |
|
NCBI chr 8:46,142,060...46,166,268
Ensembl chr 8:46,142,116...46,165,876
|
|
G |
Bag3 |
BAG cochaperone 3 |
increases expression |
ISO |
cupric chloride results in increased expression of BAG3 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:183,103,038...183,126,862
Ensembl chr 1:183,102,871...183,126,858
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
ISO |
cupric chloride results in increased expression of BAX protein [cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of BAX protein; [prolinedithiocarbamate analog co-treated with cupric chloride] results in increased expression of BAX protein; CAT protein inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of BAX protein]; Ethanol inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of BAX protein]; Mannitol inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of BAX protein]; neocuproine inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of BAX protein]; Thiourea inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of BAX protein] |
CTD |
PMID:21035945 PMID:22239859 PMID:23313662 PMID:24170445 PMID:29803612 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
EXP ISO |
[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in decreased expression of BCL2 mRNA; [cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in decreased expression of BCL2 protein; pyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in decreased expression of BCL2 mRNA]; pyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in decreased expression of BCL2 protein] [Disulfiram co-treated with cupric chloride] results in decreased expression of BCL2 protein cupric chloride results in decreased expression of BCL2 protein |
CTD |
PMID:20920558 PMID:21911303 PMID:23313662 PMID:24170445 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression |
ISO |
cupric chloride results in decreased expression of BCL2L1 protein |
CTD |
PMID:23313662 PMID:24170445 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Bid |
BH3 interacting domain death agonist |
increases expression |
ISO |
cupric chloride results in increased expression of BID mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Blvrb |
biliverdin reductase B |
increases expression |
ISO |
cupric chloride results in increased expression of BLVRB mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375
|
|
G |
C1qtnf4 |
C1q and TNF related 4 |
increases expression |
ISO |
cupric chloride results in increased expression of C1QTNF4 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 3:76,854,368...76,872,991
Ensembl chr 3:76,857,735...76,874,139
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases expression increases activity decreases activity |
EXP ISO |
[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased cleavage of CASP3 protein; [Disulfiram binds to cupric chloride] which results in increased activity of CASP3 protein; bathocuproine sulfonate inhibits the reaction [[Disulfiram binds to cupric chloride] which results in increased activity of CASP3 protein]; MAPK8 protein promotes the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased activity of CASP3 protein]; pyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased cleavage of CASP3 protein] [cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased activity of CASP3 protein; [prolinedithiocarbamate analog co-treated with cupric chloride] results in increased activity of CASP3 protein; CAT protein inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased activity of CASP3 protein]; Ethanol inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased activity of CASP3 protein]; Mannitol inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased activity of CASP3 protein]; neocuproine inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased activity of CASP3 protein]; Thiourea inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased activity of CASP3 protein] cupric chloride results in increased expression of CASP3 protein cupric chloride results in increased activity of CASP3 protein cupric chloride results in decreased activity of CASP3 protein |
CTD |
PMID:11239917 PMID:18056745 PMID:20920558 PMID:21035945 PMID:22954531 PMID:23313662 PMID:24170445 PMID:29803612 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
multiple interactions |
EXP ISO |
[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased cleavage of CASP7 protein; MAPK8 protein promotes the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased activity of CASP7 protein]; pyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased cleavage of CASP7 protein] [prolinedithiocarbamate analog co-treated with cupric chloride] results in increased activity of CASP7 protein; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[prolinedithiocarbamate analog co-treated with cupric chloride] results in increased activity of CASP7 protein] |
CTD |
PMID:20920558 PMID:21035945 |
|
NCBI chr 1:255,437,195...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
increases expression |
ISO |
cupric chloride results in increased expression of CASP8 protein |
CTD |
PMID:23313662 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases expression |
EXP ISO |
[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased cleavage of CASP9 protein; MAPK8 protein promotes the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased activity of CASP9 protein]; pyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased cleavage of CASP9 protein] cupric chloride results in increased expression of CASP9 protein |
CTD |
PMID:20920558 PMID:23313662 PMID:24170445 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions decreases activity |
ISO |
Carnosine inhibits the reaction [cupric chloride results in decreased activity of CAT protein]; CAT protein inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased activity of CASP3 protein]; CAT protein inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of BAX protein]; CAT protein inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of TP53 protein] |
CTD |
PMID:29803612 PMID:32745495 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccn1 |
cellular communication network factor 1 |
increases expression |
ISO |
cupric chloride results in increased expression of CCN1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
|
|
G |
Ccs |
copper chaperone for superoxide dismutase |
multiple interactions |
ISO |
cupric chloride results in increased degradation of and results in decreased expression of CCS protein |
CTD |
PMID:16531609 |
|
NCBI chr 1:202,113,792...202,134,931
Ensembl chr 1:202,113,804...202,134,915
|
|
G |
Cd63 |
Cd63 molecule |
decreases expression |
ISO |
cupric chloride results in decreased expression of CD63 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 7:1,325,108...1,340,447
Ensembl chr 7:1,325,103...1,399,178
|
|
G |
Cdc34 |
cell division cycle 34, ubiqiutin conjugating enzyme |
affects expression |
ISO |
cupric chloride affects the expression of CDC34 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 7:10,017,588...10,023,586
Ensembl chr 7:10,017,588...10,023,186
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
affects expression |
ISO |
cupric chloride affects the expression of CDKN1A mRNA |
CTD |
PMID:17211630 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
affects expression |
ISO |
cupric chloride affects the expression of CDKN1B protein |
CTD |
PMID:23313662 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Chordc1 |
cysteine and histidine rich domain containing 1 |
increases expression |
ISO |
cupric chloride results in increased expression of CHORDC1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 8:15,374,356...15,398,436
Ensembl chr 8:15,374,471...15,399,162
|
|
G |
Ckmt2 |
creatine kinase, mitochondrial 2 |
decreases expression |
ISO |
cupric chloride results in decreased expression of CKMT2 protein |
CTD |
PMID:29617964 |
|
NCBI chr 2:23,079,920...23,110,518
Ensembl chr 2:23,079,918...23,110,430
|
|
G |
Cks2 |
CDC28 protein kinase regulatory subunit 2 |
increases expression |
ISO |
cupric chloride results in increased expression of CKS2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr17:13,570,611...13,575,770
|
|
G |
Clcn6 |
chloride voltage-gated channel 6 |
increases expression decreases expression |
ISO |
cupric chloride results in increased expression of CLCN6 mRNA cupric chloride results in decreased expression of CLCN6 mRNA |
CTD |
PMID:17211630 PMID:34921933 |
|
NCBI chr 5:158,434,299...158,465,174
Ensembl chr 5:158,434,299...158,465,059
|
|
G |
Clcn7 |
chloride voltage-gated channel 7 |
affects expression |
ISO |
cupric chloride affects the expression of CLCN7 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr10:14,151,758...14,177,130
Ensembl chr10:14,151,758...14,177,130
|
|
G |
Cldnd1 |
claudin domain containing 1 |
increases expression |
ISO |
cupric chloride results in increased expression of CLDND1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr11:41,883,120...41,889,471
Ensembl chr11:41,883,134...41,889,354
|
|
G |
Clu |
clusterin |
multiple interactions increases expression |
ISO |
cupric chloride promotes the reaction [CLU protein binds to ATP7A protein]; cupric chloride promotes the reaction [CLU protein binds to ATP7B protein] cupric chloride results in increased expression of CLU mRNA |
CTD |
PMID:17211630 PMID:21242307 |
|
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Commd1 |
copper metabolism domain containing 1 |
decreases response to substance multiple interactions decreases expression |
ISO EXP |
COMMD1 protein results in decreased susceptibility to cupric chloride cupric chloride promotes the reaction [COMMD1 protein binds to SOD1 protein] [COMMD1 protein co-treated with zinc chloride co-treated with cupric chloride] results in increased expression of SHANK2 protein; [COMMD1 protein co-treated with zinc chloride co-treated with cupric chloride] results in increased expression of SHANK3 protein cupric chloride results in decreased expression of COMMD1 mRNA; cupric chloride results in decreased expression of COMMD1 protein |
CTD |
PMID:17211630 PMID:24691167 PMID:25007851 |
|
NCBI chr14:96,880,463...96,984,494
Ensembl chr14:96,880,463...96,984,501
|
|
G |
Commd10 |
COMM domain containing 10 |
decreases expression |
ISO |
cupric chloride results in decreased expression of COMMD10 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr18:39,741,219...39,874,801
Ensembl chr18:39,741,298...39,874,903
|
|
G |
Commd2 |
COMM domain containing 2 |
decreases expression |
ISO |
cupric chloride results in decreased expression of COMMD2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 2:141,848,661...141,852,907
Ensembl chr 2:141,848,680...141,852,888
|
|
G |
Commd3 |
COMM domain containing 3 |
decreases expression |
ISO |
cupric chloride results in decreased expression of COMMD3 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr17:81,327,451...81,331,183
Ensembl chr17:81,327,405...81,331,177
|
|
G |
Commd4 |
COMM domain containing 4 |
decreases expression |
ISO |
cupric chloride results in decreased expression of COMMD4 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 8:57,566,236...57,569,794
Ensembl chr 8:57,566,236...57,569,760
|
|
G |
Commd5 |
COMM domain containing 5 |
decreases expression |
ISO |
cupric chloride results in decreased expression of COMMD5 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 7:108,621,766...108,623,616
Ensembl chr 7:108,598,673...108,624,764
|
|
G |
Commd6 |
COMM domain containing 6 |
decreases expression |
ISO |
cupric chloride results in decreased expression of COMMD6 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr15:78,467,333...78,474,382
Ensembl chr15:78,467,804...78,474,382
|
|
G |
Commd7 |
COMM domain containing 7 |
decreases expression |
ISO |
cupric chloride results in decreased expression of COMMD7 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 3:142,099,566...142,114,348
Ensembl chr 3:142,099,251...142,114,317
|
|
G |
Commd8 |
COMM domain containing 8 |
decreases expression |
ISO |
cupric chloride results in decreased expression of COMMD8 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr14:36,049,040...36,059,617
Ensembl chr14:36,049,004...36,059,617
|
|
G |
Cox16 |
cytochrome c oxidase assembly factor COX16 |
affects expression |
ISO |
cupric chloride affects the expression of COX16 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 6:101,162,231...101,181,277
Ensembl chr 6:101,019,680...101,181,246
|
|
G |
Cox5b |
cytochrome c oxidase subunit 5B |
decreases expression |
ISO |
cupric chloride results in decreased expression of COX5B protein |
CTD |
PMID:29617964 |
|
NCBI chr 9:38,921,980...38,923,806
Ensembl chr 9:38,921,967...38,925,052
|
|
G |
Cox6a1 |
cytochrome c oxidase subunit 6A1 |
increases expression |
ISO |
cupric chloride results in increased expression of COX6A1 protein |
CTD |
PMID:29617964 |
|
NCBI chr12:41,261,983...41,265,037
Ensembl chr12:41,261,967...41,265,041
|
|
G |
Cp |
ceruloplasmin |
increases expression |
ISO |
cupric chloride results in increased expression of CP mRNA |
CTD |
PMID:15741220 |
|
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
|
|
G |
Cplx2 |
complexin 2 |
decreases expression |
ISO |
cupric chloride results in decreased expression of CPLX2 protein |
CTD |
PMID:29617964 |
|
NCBI chr17:10,219,577...10,292,835
Ensembl chr17:10,222,347...10,293,855
|
|
G |
Cryab |
crystallin, alpha B |
increases expression |
ISO |
cupric chloride results in increased expression of CRYAB mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 8:51,093,441...51,099,161
Ensembl chr 8:51,093,441...51,099,157
|
|
G |
Csnk1g1 |
casein kinase 1, gamma 1 |
decreases expression |
ISO |
cupric chloride results in decreased expression of CSNK1G1 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr 8:66,439,760...66,577,247
Ensembl chr 8:66,439,864...66,572,826
|
|
G |
Cstb |
cystatin B |
affects binding |
ISO |
CSTB protein binds to cupric chloride |
CTD |
PMID:16939620 |
|
NCBI chr20:10,245,462...10,247,505
Ensembl chr20:10,245,462...10,247,526
|
|
G |
Ctsb |
cathepsin B |
multiple interactions decreases expression |
ISO |
PP242 inhibits the reaction [cupric chloride results in decreased expression of CTSB mRNA]; PP242 inhibits the reaction [cupric chloride results in decreased expression of CTSB protein] cupric chloride results in decreased expression of CTSB mRNA; cupric chloride results in decreased expression of CTSB protein |
CTD |
PMID:32512069 |
|
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
|
|
G |
Ctsd |
cathepsin D |
decreases expression multiple interactions |
ISO |
cupric chloride results in decreased expression of CTSD mRNA PP242 inhibits the reaction [cupric chloride results in decreased expression of CTSD mRNA] |
CTD |
PMID:32512069 |
|
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Cybc1 |
cytochrome b-245 chaperone 1 |
increases expression |
ISO |
cupric chloride results in increased expression of CYBC1 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr10:106,498,730...106,505,549
Ensembl chr10:106,498,725...106,505,596
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
EXP |
[cupric chloride binds to pyrrolidine dithiocarbamic acid] which affects the localization of CYCS protein |
CTD |
PMID:20920558 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054
|
|
G |
Cyfip2 |
cytoplasmic FMR1 interacting protein 2 |
decreases expression |
ISO |
cupric chloride results in decreased expression of CYFIP2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr10:30,621,318...30,741,113
Ensembl chr10:30,621,318...30,741,113
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases stability multiple interactions |
ISO |
cupric chloride results in increased stability of CYP1A1 mRNA; cupric chloride results in increased stability of CYP1A1 protein [1,10-phenanthroline co-treated with cupric chloride] inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; [1,10-phenanthroline co-treated with cupric chloride] inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 protein] |
CTD |
PMID:19896525 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
increases expression |
ISO |
cupric chloride results in increased expression of CYP27A1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
multiple interactions |
ISO |
[CYP2B6 protein co-treated with cupric chloride co-treated with NADP] results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone; [CYP2B6 protein co-treated with cupric chloride co-treated with NADP] results in increased metabolism of N'-nitrosonornicotine |
CTD |
PMID:32672941 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c6v1 |
cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 |
increases expression |
ISO |
cupric chloride results in increased expression of CYP2C38 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp51 |
cytochrome P450, family 51 |
decreases expression |
ISO |
cupric chloride results in decreased expression of CYP51A1 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions increases expression |
EXP ISO |
pyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased expression of DDIT3 mRNA] cupric chloride results in increased expression of DDIT3 mRNA |
CTD |
PMID:17211630 PMID:20920558 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Derl3 |
derlin 3 |
decreases expression |
ISO |
cupric chloride results in decreased expression of DERL3 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr20:12,754,490...12,768,454
Ensembl chr20:12,763,543...12,767,027
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
decreases expression |
ISO |
cupric chloride results in decreased expression of DHCR7 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
|
|
G |
Dkk1 |
dickkopf WNT signaling pathway inhibitor 1 |
increases expression |
ISO |
cupric chloride results in increased expression of DKK1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:228,381,521...228,385,202
Ensembl chr 1:228,381,521...228,385,202
|
|
G |
Dmd |
dystrophin |
increases expression |
ISO |
cupric chloride results in increased expression of DMD mRNA |
CTD |
PMID:17211630 |
|
NCBI chr X:47,272,324...49,504,219
Ensembl chr X:47,272,331...49,504,207
|
|
G |
Dnajb1 |
DnaJ heat shock protein family (Hsp40) member B1 |
increases expression |
ISO |
cupric chloride results in increased expression of DNAJB1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr19:24,522,717...24,526,458
Ensembl chr19:24,522,717...24,526,458
|
|
G |
Dpysl2 |
dihydropyrimidinase-like 2 |
increases expression |
ISO |
cupric chloride results in increased expression of DPYSL2 protein |
CTD |
PMID:29617964 |
|
NCBI chr15:41,005,551...41,111,724
Ensembl chr15:41,005,551...41,111,829
|
|
G |
Dpysl5 |
dihydropyrimidinase-like 5 |
increases expression |
ISO |
cupric chloride results in increased expression of DPYSL5 protein |
CTD |
PMID:29617964 |
|
NCBI chr 6:25,575,104...25,659,422
Ensembl chr 6:25,575,104...25,659,422
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
increases expression |
ISO |
cupric chloride results in increased expression of DUSP1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr10:16,680,489...16,683,276
|
|
G |
Ebp |
EBP, cholestenol delta-isomerase |
decreases expression |
ISO |
cupric chloride results in decreased expression of EBP mRNA |
CTD |
PMID:34921933 |
|
NCBI chr X:14,299,427...14,305,826
Ensembl chr X:14,299,448...14,305,826
|
|
G |
Egr1 |
early growth response 1 |
affects expression |
ISO |
cupric chloride affects the expression of EGR1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr18:26,463,333...26,465,531
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Elac2 |
elaC ribonuclease Z 2 |
affects expression |
ISO |
cupric chloride affects the expression of ELAC2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr10:49,632,308...49,655,614
Ensembl chr10:49,632,378...49,655,614
|
|
G |
Elovl1 |
ELOVL fatty acid elongase 1 |
increases expression |
ISO |
cupric chloride results in increased expression of ELOVL1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 5:131,961,478...131,965,961
Ensembl chr 5:131,961,322...131,965,958
|
|
G |
Elovl6 |
ELOVL fatty acid elongase 6 |
decreases expression |
ISO |
cupric chloride results in decreased expression of ELOVL6 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186
|
|
G |
Eml4 |
EMAP like 4 |
decreases expression |
ISO |
cupric chloride results in decreased expression of EML4 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 6:11,219,545...11,334,824
Ensembl chr 6:11,219,566...11,334,879
|
|
G |
Enam |
enamelin |
affects expression |
ISO |
cupric chloride affects the expression of ENAM mRNA |
CTD |
PMID:17211630 |
|
NCBI chr14:19,556,729...19,581,433
Ensembl chr14:19,556,729...19,581,425
|
|
G |
Endog |
endonuclease G |
increases expression |
ISO |
cupric chloride results in increased expression of ENDOG protein |
CTD |
PMID:22239859 |
|
NCBI chr 3:13,449,113...13,451,715
Ensembl chr 3:13,449,086...13,451,932
|
|
G |
Erg28 |
ergosterol biosynthesis 28 homolog |
decreases expression |
ISO |
cupric chloride results in decreased expression of ERG28 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr 6:105,474,112...105,483,078
Ensembl chr 6:105,474,113...105,483,078
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions increases activity affects response to substance decreases expression |
ISO |
cupric chloride inhibits the reaction [Estradiol binds to ESR1 protein]; cupric chloride promotes the reaction [Estradiol results in decreased expression of ESR1 mRNA]; cupric chloride promotes the reaction [Estradiol results in decreased expression of ESR1 protein]; Estradiol promotes the reaction [cupric chloride results in decreased expression of ESR1 mRNA]; Estradiol promotes the reaction [cupric chloride results in decreased expression of ESR1 protein] cupric chloride results in increased activity of ESR1 protein ESR1 protein affects the susceptibility to cupric chloride cupric chloride results in decreased expression of ESR1 mRNA; cupric chloride results in decreased expression of ESR1 protein |
CTD |
PMID:12746304 PMID:17716812 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
F2 |
coagulation factor II |
increases expression |
ISO |
cupric chloride results in increased expression of F2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
Fam219a |
family with sequence similarity 219, member A |
increases expression |
ISO |
cupric chloride results in increased expression of FAM219A mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 5:56,679,272...56,729,959
Ensembl chr 5:56,680,613...56,729,924
|
|
G |
Fam89b |
family with sequence similarity 89, member B |
increases expression |
ISO |
cupric chloride results in increased expression of FAM89B mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:203,015,772...203,017,890
Ensembl chr 1:203,015,773...203,017,367
|
|
G |
Fasn |
fatty acid synthase |
decreases expression |
ISO |
cupric chloride results in decreased expression of FASN mRNA |
CTD |
PMID:34921933 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
decreases expression |
ISO |
cupric chloride results in decreased expression of FDFT1 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
|
|
G |
Fetub |
fetuin B |
increases expression |
ISO |
cupric chloride results in increased expression of FETUB mRNA |
CTD |
PMID:17211630 |
|
NCBI chr11:78,082,158...78,093,022
Ensembl chr11:78,082,156...78,095,135
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
multiple interactions |
ISO |
[amlexanox binds to FGF1 protein] inhibits the reaction [cupric chloride results in increased oxidation of FGF1 protein] |
CTD |
PMID:16300395 |
|
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
|
|
G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
affects expression |
ISO |
cupric chloride affects the expression of FGFR1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr16:66,492,445...66,546,731
Ensembl chr16:66,494,042...66,547,350
|
|
G |
Fhl3 |
four and a half LIM domains 3 |
increases expression |
ISO |
cupric chloride results in increased expression of FHL3 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 5:136,953,947...136,961,317
Ensembl chr 5:136,950,411...136,961,317
|
|
G |
Fkbp4 |
FKBP prolyl isomerase 4 |
increases expression |
ISO |
cupric chloride results in increased expression of FKBP4 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 4:161,703,379...161,711,833
Ensembl chr 4:161,703,379...161,711,833
|
|
G |
Fmo5 |
flavin containing dimethylaniline monoxygenase 5 |
decreases expression |
ISO |
cupric chloride results in decreased expression of FMO5 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 2:185,197,184...185,249,699
Ensembl chr 2:185,222,204...185,249,693
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
cupric chloride results in increased expression of FOS mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fubp1 |
far upstream element binding protein 1 |
increases expression |
ISO |
cupric chloride results in increased expression of FUBP1 protein |
CTD |
PMID:29617964 |
|
NCBI chr 2:241,159,481...241,186,591
Ensembl chr 2:241,159,512...241,186,602
|
|
G |
Fxyd2 |
FXYD domain-containing ion transport regulator 2 |
affects expression |
ISO |
cupric chloride affects the expression of FXYD2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 8:45,712,887...45,720,032
Ensembl chr 8:45,712,903...45,720,203
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
decreases activity multiple interactions |
ISO |
cupric chloride results in decreased activity of G6PD protein Carnosine inhibits the reaction [cupric chloride results in decreased activity of G6PD protein] |
CTD |
PMID:32745495 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gabre |
gamma-aminobutyric acid type A receptor subunit epsilon |
increases expression |
ISO |
cupric chloride results in increased expression of GABRE mRNA |
CTD |
PMID:17211630 |
|
NCBI chr X:150,060,035...150,078,773
Ensembl chr X:150,060,040...150,078,693
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression |
ISO |
cupric chloride results in increased expression of GADD45A mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression |
ISO |
cupric chloride results in increased expression of GCLC mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
ISO |
cupric chloride results in increased expression of GCLM mRNA |
CTD |
PMID:17211630 PMID:24343273 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gdi1 |
GDP dissociation inhibitor 1 |
increases expression |
ISO |
cupric chloride results in increased expression of GDI1 protein |
CTD |
PMID:29617964 |
|
NCBI chr X:152,087,611...152,094,274
Ensembl chr X:152,087,444...152,094,272
|
|
G |
Gla |
galactosidase, alpha |
increases expression |
ISO |
cupric chloride results in increased expression of GLA mRNA |
CTD |
PMID:17211630 |
|
NCBI chr X:97,769,227...97,780,646
Ensembl chr X:97,768,996...97,780,664
|
|
G |
Glud1 |
glutamate dehydrogenase 1 |
decreases expression |
ISO |
cupric chloride results in decreased expression of GLUD1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr16:9,640,312...9,673,961
Ensembl chr16:9,640,312...9,673,957
|
|
G |
Gprc5c |
G protein-coupled receptor, class C, group 5, member C |
decreases expression |
ISO |
cupric chloride results in decreased expression of GPRC5C mRNA |
CTD |
PMID:34921933 |
|
NCBI chr10:99,886,900...99,908,928
Ensembl chr10:99,887,077...99,908,926
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions decreases activity |
ISO |
Carnosine inhibits the reaction [cupric chloride results in decreased activity of GSR protein] |
CTD |
PMID:32745495 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gtpbp2 |
GTP binding protein 2 |
affects expression |
ISO |
cupric chloride affects the expression of GTPBP2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 9:14,813,964...14,823,419
Ensembl chr 9:14,813,964...14,823,241
|
|
G |
Gtpbp6 |
GTP binding protein 6 (putative) |
increases expression |
ISO |
cupric chloride results in increased expression of GTPBP6 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr12:46,574,913...46,578,873
Ensembl chr12:46,574,435...46,578,873
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
increases expression |
ISO |
cupric chloride results in increased expression of HAMP mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
|
|
G |
Hexa |
hexosaminidase subunit alpha |
decreases expression multiple interactions |
ISO |
cupric chloride results in decreased expression of HEXA mRNA PP242 inhibits the reaction [cupric chloride results in decreased expression of HEXA mRNA] |
CTD |
PMID:32512069 |
|
NCBI chr 8:59,936,526...59,961,654
Ensembl chr 8:59,936,660...59,962,013
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions increases stability affects localization decreases hydroxylation |
ISO |
Ascorbic Acid inhibits the reaction [cupric chloride results in decreased hydroxylation of HIF1A protein]; Ascorbic Acid inhibits the reaction [cupric chloride results in increased stability of HIF1A protein]; cupric chloride results in decreased hydroxylation of and results in decreased degradation of HIF1A protein cupric chloride affects the localization of HIF1A protein |
CTD |
PMID:15741220 PMID:19074761 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hist1h2bc |
histone cluster 1, H2bc |
decreases expression |
ISO |
cupric chloride results in decreased expression of H2BC21 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr17:42,692,335...42,696,860
Ensembl chr17:42,694,723...42,696,642
|
|
G |
Hk1 |
hexokinase 1 |
decreases activity |
EXP |
cupric chloride results in decreased activity of HK1 protein |
CTD |
PMID:22349057 |
|
NCBI chr20:30,230,488...30,332,161
Ensembl chr20:30,230,486...30,332,131
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
decreases expression |
ISO |
cupric chloride results in decreased expression of HMGCR mRNA |
CTD |
PMID:34921933 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
decreases expression |
ISO |
cupric chloride results in decreased expression of HMGCS1 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO |
cupric chloride results in increased expression of HMOX1 mRNA; cupric chloride results in increased expression of HMOX1 protein |
CTD |
PMID:17211630 PMID:21242307 PMID:24343273 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hsd17b7 |
hydroxysteroid (17-beta) dehydrogenase 7 |
decreases expression |
ISO |
cupric chloride results in decreased expression of HSD17B7 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr13:82,170,079...82,190,018
Ensembl chr13:82,173,179...82,190,017
|
|
G |
Hsp90aa1 |
heat shock protein 90 alpha family class A member 1 |
increases expression |
ISO |
cupric chloride results in increased expression of HSP90AA1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
|
|
G |
Hsp90b1 |
heat shock protein 90 beta family member 1 |
multiple interactions |
EXP |
[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased expression of HSP90B1 mRNA; [cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased expression of HSP90B1 protein; pyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased expression of HSP90B1 mRNA] |
CTD |
PMID:20920558 |
|
NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:21,110,457...21,124,788
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
increases expression |
ISO |
cupric chloride results in increased expression of HSPA1B mRNA |
CTD |
PMID:17211630 |
|
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
affects expression |
ISO |
cupric chloride affects the expression of HSPA1A mRNA |
CTD |
PMID:20945374 |
|
NCBI chr20:3,870,765...3,873,221
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions |
EXP |
[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased expression of HSPA5 mRNA; [cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased expression of HSPA5 protein; pyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased expression of HSPA5 mRNA] |
CTD |
PMID:20920558 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspa6l-ps1 |
heat shock protein family A (Hsp70) member 6 like, pseudogene 1 |
increases expression |
ISO |
cupric chloride results in increased expression of HSPA6 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr13:83,271,340...83,275,267
|
|
G |
Hspa9 |
heat shock protein family A (Hsp70) member 9 |
decreases expression |
ISO |
cupric chloride results in decreased expression of HSPA9 protein |
CTD |
PMID:29617964 |
|
NCBI chr18:26,536,131...26,554,294
Ensembl chr18:26,535,798...26,554,292
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
increases expression |
ISO |
cupric chloride results in increased expression of HSPB1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Id2 |
inhibitor of DNA binding 2 |
affects expression |
ISO |
cupric chloride affects the expression of ID2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
|
|
G |
Idh3a |
isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha |
decreases expression |
ISO |
cupric chloride results in decreased expression of IDH3A protein |
CTD |
PMID:29617964 |
|
NCBI chr 8:54,971,694...54,991,085
Ensembl chr 8:54,971,740...54,991,084
|
|
G |
Idi1 |
isopentenyl-diphosphate delta isomerase 1 |
decreases expression |
ISO |
cupric chloride results in decreased expression of IDI1 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
|
|
G |
Ier2 |
immediate early response 2 |
increases expression |
ISO |
cupric chloride results in increased expression of IER2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr19:23,494,551...23,496,075
Ensembl chr19:23,494,184...23,499,211
|
|
G |
Ier5 |
immediate early response 5 |
increases expression |
ISO |
cupric chloride results in increased expression of IER5 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr13:67,270,134...67,272,226
Ensembl chr13:67,270,135...67,272,227
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
cupric chloride inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]] |
CTD |
PMID:8975779 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Igf1 |
insulin-like growth factor 1 |
increases expression |
ISO |
cupric chloride results in increased expression of IGF1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Ighmbp2 |
immunoglobulin mu DNA binding protein 2 |
increases expression |
ISO |
cupric chloride results in increased expression of IGHMBP2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:200,506,641...200,529,293
Ensembl chr 1:200,506,338...200,529,514
|
|
G |
Ikbkg |
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma |
increases expression |
ISO |
cupric chloride results in increased expression of IKBKG mRNA |
CTD |
PMID:17211630 |
|
NCBI chr X:152,216,485...152,241,476
Ensembl chr X:152,216,596...152,239,499
|
|
G |
Il1a |
interleukin 1 alpha |
increases secretion |
ISO |
cupric chloride results in increased secretion of IL1A protein |
CTD |
PMID:22954531 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
cupric chloride inhibits the reaction [TNF protein results in increased secretion of IL6 protein] |
CTD |
PMID:23285694 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Immt |
inner membrane mitochondrial protein |
decreases expression |
ISO |
cupric chloride results in decreased expression of IMMT protein |
CTD |
PMID:29617964 |
|
NCBI chr 4:103,880,482...103,919,116
Ensembl chr 4:103,880,459...103,919,109
|
|
G |
Irs2 |
insulin receptor substrate 2 |
increases expression |
ISO |
cupric chloride results in increased expression of IRS2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr16:78,488,249...78,512,482
Ensembl chr16:78,485,045...78,512,482
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
increases expression multiple interactions |
ISO |
cupric chloride results in increased expression of JUN mRNA [[cupric chloride results in increased abundance of Copper] co-treated with [zinc chloride results in increased abundance of Zinc]] results in increased phosphorylation of JUN protein; pyrazolanthrone inhibits the reaction [[[cupric chloride results in increased abundance of Copper] co-treated with [zinc chloride results in increased abundance of Zinc]] results in increased phosphorylation of JUN protein] [Disulfiram co-treated with cupric chloride co-treated with Doxorubicin] results in increased expression of and results in increased phosphorylation of JUN protein |
CTD |
PMID:17211630 PMID:21911303 PMID:30768131 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kcnip1 |
potassium voltage-gated channel interacting protein 1 |
increases expression |
ISO |
cupric chloride results in increased expression of KCNIP1 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr10:18,219,519...18,588,833
Ensembl chr10:18,219,519...18,589,045
|
|
G |
Kdm2a |
lysine demethylase 2A |
increases expression |
ISO |
cupric chloride results in increased expression of KDM2A mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:201,612,427...201,682,359
Ensembl chr 1:201,612,453...201,680,787
|
|
G |
Kdm3a |
lysine demethylase 3A |
increases expression |
ISO |
cupric chloride results in increased expression of KDM3A mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 4:103,630,907...103,675,073
Ensembl chr 4:103,630,908...103,675,073
|
|
G |
Kif5a |
kinesin family member 5A |
decreases activity multiple interactions |
ISO |
cupric chloride results in decreased activity of KIF5A protein Cysteine inhibits the reaction [cupric chloride results in decreased activity of KIF5A protein]; Dithiothreitol inhibits the reaction [cupric chloride results in decreased activity of KIF5A protein]; Egtazic Acid inhibits the reaction [cupric chloride results in decreased activity of KIF5A protein] |
CTD |
PMID:24853401 |
|
NCBI chr 7:63,051,894...63,089,024
Ensembl chr 7:63,049,424...63,092,858
|
|
G |
Klf6 |
KLF transcription factor 6 |
affects expression |
ISO |
cupric chloride affects the expression of KLF6 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr17:64,539,456...64,548,451
Ensembl chr17:64,531,463...64,588,570
|
|
G |
Kng2 |
kininogen 2 |
increases expression |
ISO |
cupric chloride results in increased expression of KNG1 mRNA; cupric chloride results in increased expression of KNG2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr11:77,913,876...77,936,247
Ensembl chr11:77,909,612...78,002,971
|
|
G |
Lamp1 |
lysosomal-associated membrane protein 1 |
decreases expression multiple interactions |
ISO |
cupric chloride results in decreased expression of LAMP1 mRNA; cupric chloride results in decreased expression of LAMP1 protein PP242 inhibits the reaction [cupric chloride results in decreased expression of LAMP1 mRNA]; PP242 inhibits the reaction [cupric chloride results in decreased expression of LAMP1 protein] |
CTD |
PMID:32512069 |
|
NCBI chr16:76,355,982...76,380,700
Ensembl chr16:76,355,984...76,381,883
|
|
G |
Lamp2 |
lysosomal-associated membrane protein 2 |
decreases expression multiple interactions |
ISO |
cupric chloride results in decreased expression of LAMP2 mRNA PP242 inhibits the reaction [cupric chloride results in decreased expression of LAMP2 mRNA] |
CTD |
PMID:32512069 |
|
NCBI chr X:117,173,097...117,222,090
Ensembl chr X:117,057,606...117,260,522
|
|
G |
Lcat |
lecithin cholesterol acyltransferase |
increases expression |
ISO |
cupric chloride results in increased expression of LCAT mRNA |
CTD |
PMID:17211630 |
|
NCBI chr19:33,834,748...33,838,214
Ensembl chr19:33,834,403...33,838,231
|
|
G |
Lox |
lysyl oxidase |
increases activity multiple interactions |
ISO |
cupric chloride results in increased activity of LOX protein Aminopropionitrile inhibits the reaction [cupric chloride results in increased activity of LOX protein] |
CTD |
PMID:22367676 PMID:25044713 |
|
NCBI chr18:45,964,311...46,041,477
Ensembl chr18:45,967,343...46,041,477
|
|
G |
Ly6e |
lymphocyte antigen 6 family member E |
increases expression |
ISO |
cupric chloride results in increased expression of LY6E mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 7:106,935,530...106,939,689
Ensembl chr 7:106,935,761...106,939,689
|
|
G |
Mad2l1bp |
MAD2L1 binding protein |
increases expression |
ISO |
cupric chloride results in increased expression of MAD2L1BP mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 9:14,832,133...14,836,458
Ensembl chr 9:14,832,132...14,837,447
|
|
G |
Mafg |
MAF bZIP transcription factor G |
increases expression |
ISO |
cupric chloride results in increased expression of MAFG mRNA |
CTD |
PMID:17211630 |
|
NCBI chr10:105,903,307...105,911,845
Ensembl chr10:105,903,237...105,912,026
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
increases expression multiple interactions |
ISO |
cupric chloride results in increased expression of MAP1LC3B mRNA Acetylcysteine inhibits the reaction [cupric chloride results in increased expression of MAP1LC3B protein modified form]; cupric chloride inhibits the reaction [3-methyladenine results in decreased expression of MAP1LC3B protein modified form]; PP242 promotes the reaction [cupric chloride results in increased expression of MAP1LC3B protein modified form] |
CTD |
PMID:17211630 PMID:32512069 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
EXP |
[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:20920558 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
EXP |
[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:20920558 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
EXP ISO |
[Disulfiram binds to cupric chloride] which results in increased activity of MAPK8 protein; bathocuproine sulfonate inhibits the reaction [[Disulfiram binds to cupric chloride] which results in increased activity of MAPK8 protein]; MAPK8 protein promotes the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased activity of CASP3 protein]; MAPK8 protein promotes the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased activity of CASP7 protein]; MAPK8 protein promotes the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased activity of CASP9 protein] [[cupric chloride results in increased abundance of Copper] co-treated with [zinc chloride results in increased abundance of Zinc]] results in increased phosphorylation of MAPK8 protein; pyrazolanthrone inhibits the reaction [[[cupric chloride results in increased abundance of Copper] co-treated with [zinc chloride results in increased abundance of Zinc]] results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:11239917 PMID:20920558 PMID:30768131 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mcm2 |
minichromosome maintenance complex component 2 |
multiple interactions |
ISO |
cupric chloride promotes the reaction [Disulfiram results in decreased expression of MCM2 mRNA] |
CTD |
PMID:19789329 |
|
NCBI chr 4:121,346,434...121,360,962
Ensembl chr 4:121,346,434...121,360,847
|
|
G |
Mcm5 |
minichromosome maintenance complex component 5 |
multiple interactions |
ISO |
cupric chloride promotes the reaction [Disulfiram results in decreased expression of MCM5 mRNA] |
CTD |
PMID:19789329 |
|
NCBI chr19:13,483,030...13,504,389
Ensembl chr19:13,483,066...13,504,389
|
|
G |
Mdh2 |
malate dehydrogenase 2 |
increases expression |
ISO |
cupric chloride results in increased expression of MDH2 protein |
CTD |
PMID:29617964 |
|
NCBI chr12:20,894,269...20,907,225
Ensembl chr12:20,894,262...20,907,271
|
|
G |
Med15 |
mediator complex subunit 15 |
increases expression |
ISO |
cupric chloride results in increased expression of MED15 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr11:83,280,722...83,356,006
Ensembl chr11:83,280,762...83,355,362
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
multiple interactions |
ISO |
[Disulfiram co-treated with cupric chloride] affects the expression of and affects the activity of MGMT protein |
CTD |
PMID:24193513 |
|
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
|
|
G |
Mllt11 |
MLLT11, transcription factor 7 cofactor |
increases expression |
ISO |
cupric chloride results in increased expression of MLLT11 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 2:182,795,790...182,804,960
Ensembl chr 2:182,795,790...182,797,199
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
increases secretion |
EXP |
cupric chloride results in increased secretion of MMP2 protein |
CTD |
PMID:11045606 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mrpl4 |
mitochondrial ribosomal protein L4 |
increases expression |
ISO |
cupric chloride results in increased expression of MRPL4 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 8:19,539,593...19,545,608
Ensembl chr 8:19,539,593...19,545,608
|
|
G |
Msrb1 |
methionine sulfoxide reductase B1 |
increases expression |
ISO |
cupric chloride results in increased expression of MSRB1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr10:13,764,883...13,770,609
Ensembl chr10:13,764,883...13,770,609
|
|
G |
Mt1 |
metallothionein 1 |
increases expression |
EXP ISO |
cupric chloride results in increased expression of MT1A mRNA |
CTD |
PMID:17211630 PMID:23174565 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049
|
|
G |
Mt1-ps3 |
metallothionein 1, pseudogene 3 |
increases expression |
ISO |
cupric chloride results in increased expression of MT1E mRNA |
CTD |
PMID:17211630 |
|
NCBI chr17:74,786,652...74,787,040
Ensembl chr17:74,786,654...74,787,135
|
|
G |
Mt2A |
metallothionein 2A |
multiple interactions increases expression affects expression |
ISO EXP |
cupric chloride promotes the reaction [Disulfiram results in increased expression of MT2A mRNA] cupric chloride results in increased expression of MT2A mRNA cupric chloride affects the expression of MT2A mRNA |
CTD |
PMID:17211630 PMID:17409708 PMID:19789329 PMID:20945374 PMID:23174565 |
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
increases phosphorylation |
ISO |
cupric chloride results in increased phosphorylation of MTOR protein |
CTD |
PMID:32512069 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Mvd |
mevalonate diphosphate decarboxylase |
decreases expression |
ISO |
cupric chloride results in decreased expression of MVD mRNA |
CTD |
PMID:34921933 |
|
NCBI chr19:50,496,366...50,506,389
Ensembl chr19:50,496,367...50,507,971
|
|
G |
Ncf2 |
neutrophil cytosolic factor 2 |
increases expression |
ISO |
cupric chloride results in increased expression of NCF2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr13:64,955,502...64,986,289
Ensembl chr13:64,955,503...64,986,277
|
|
G |
Ndufs1 |
NADH:ubiquinone oxidoreductase core subunit S1 |
decreases expression |
ISO |
cupric chloride results in decreased expression of NDUFS1 protein |
CTD |
PMID:29617964 |
|
NCBI chr 9:64,546,430...64,579,751
Ensembl chr 9:64,546,225...64,579,893
|
|
G |
Ndufs4 |
NADH:ubiquinone oxidoreductase subunit S4 |
decreases expression |
ISO |
cupric chloride results in decreased expression of NDUFS4 protein |
CTD |
PMID:29617964 |
|
NCBI chr 2:45,951,327...46,061,829
Ensembl chr 2:45,951,313...46,061,846
|
|
G |
Ndufv1 |
NADH:ubiquinone oxidoreductase core subunit V1 |
decreases expression |
ISO |
cupric chloride results in decreased expression of NDUFV1 protein |
CTD |
PMID:29617964 |
|
NCBI chr 1:201,300,365...201,305,461
Ensembl chr 1:201,299,985...201,305,466
|
|
G |
Ndufv3 |
NADH:ubiquinone oxidoreductase subunit V3 |
decreases expression |
ISO |
cupric chloride results in decreased expression of NDUFV3 protein |
CTD |
PMID:29617964 |
|
NCBI chr20:9,612,462...9,621,622
Ensembl chr20:9,612,431...9,623,074
|
|
G |
Nefl |
neurofilament light chain |
decreases expression |
ISO |
cupric chloride results in decreased expression of NEFL protein |
CTD |
PMID:29617964 |
|
NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793
|
|
G |
Neu1 |
neuraminidase 1 |
decreases expression |
ISO |
cupric chloride results in decreased expression of NEU1 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr20:3,897,480...3,901,745
Ensembl chr20:3,897,480...3,901,745
|
|
G |
Nfix |
nuclear factor I X |
decreases expression |
ISO |
cupric chloride results in decreased expression of NFIX mRNA |
CTD |
PMID:17211630 |
|
NCBI chr19:23,355,388...23,450,360
Ensembl chr19:23,355,498...23,448,265
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
decreases expression |
EXP |
cupric chloride results in decreased expression of NFKBIA protein |
CTD |
PMID:24530511 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nme1 |
NME/NM23 nucleoside diphosphate kinase 1 |
increases expression |
ISO |
cupric chloride results in increased expression of NME1 protein |
CTD |
PMID:29617964 |
|
NCBI chr10:78,907,036...78,929,659
Ensembl chr10:78,906,083...78,916,408
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions increases expression |
ISO EXP |
cupric chloride inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]] cupric chloride results in increased expression of NOS2 protein |
CTD |
PMID:8975779 PMID:23313662 PMID:24170445 PMID:24530511 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nudt5 |
nudix hydrolase 5 |
increases expression |
ISO |
cupric chloride results in increased expression of NUDT5 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr17:72,435,690...72,459,008
Ensembl chr17:72,435,697...72,459,001
|
|
G |
Nup107 |
nucleoporin 107 |
increases expression |
ISO |
cupric chloride results in increased expression of NUP107 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 7:53,353,740...53,398,345
Ensembl chr 7:53,353,743...53,398,370
|
|
G |
P2rx2 |
purinergic receptor P2X 2 |
multiple interactions |
EXP |
cupric chloride promotes the reaction [Adenosine Triphosphate results in increased activity of P2RX2 protein] |
CTD |
PMID:16190872 |
|
NCBI chr12:46,338,979...46,342,891
Ensembl chr12:46,339,549...46,342,891
|
|
G |
P3h4 |
prolyl 3-hydroxylase family member 4 |
affects expression |
ISO |
cupric chloride affects the expression of P3H4 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr10:85,338,158...85,345,108
Ensembl chr10:85,338,161...85,345,093
|
|
G |
Palld |
palladin, cytoskeletal associated protein |
increases expression |
ISO |
cupric chloride results in increased expression of PALLD mRNA |
CTD |
PMID:17211630 |
|
NCBI chr16:28,228,006...28,621,349
Ensembl chr16:27,981,354...28,621,337
|
|
G |
Paqr8 |
progestin and adipoQ receptor family member 8 |
decreases expression |
ISO |
cupric chloride results in decreased expression of PAQR8 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 9:23,312,521...23,362,175
Ensembl chr 9:23,312,585...23,362,340
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions increases expression |
ISO |
[Disulfiram co-treated with cupric chloride] results in increased cleavage of PARP1 protein; [prolinedithiocarbamate analog co-treated with cupric chloride] results in increased cleavage of PARP1 protein cupric chloride results in increased expression of PARP1 protein |
CTD |
PMID:19789329 PMID:21035945 PMID:23313662 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pcm1 |
pericentriolar material 1 |
decreases expression |
ISO |
cupric chloride results in decreased expression of PCM1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr16:51,008,315...51,105,261
Ensembl chr16:51,008,315...51,105,091
|
|
G |
Pcyt2 |
phosphate cytidylyltransferase 2, ethanolamine |
decreases expression |
ISO |
cupric chloride results in decreased expression of PCYT2 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr10:105,888,769...105,896,182
Ensembl chr10:105,888,775...105,896,172
|
|
G |
Pdia3 |
protein disulfide isomerase family A, member 3 |
decreases expression |
ISO |
cupric chloride results in decreased expression of PDIA3 protein |
CTD |
PMID:29617964 |
|
NCBI chr 3:108,388,189...108,412,013
Ensembl chr 3:108,388,245...108,413,236
|
|
G |
Pdzk1 |
PDZ domain containing 1 |
decreases expression |
ISO |
cupric chloride results in decreased expression of PDZK1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 2:184,376,161...184,407,514
Ensembl chr 2:184,376,161...184,407,514
|
|
G |
Peg10 |
paternally expressed 10 |
decreases expression |
ISO |
cupric chloride results in decreased expression of PEG10 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 4:32,842,394...32,855,641
Ensembl chr 4:32,848,493...32,852,621
|
|
G |
Pfkp |
phosphofructokinase, platelet |
increases expression |
ISO |
cupric chloride results in increased expression of PFKP mRNA |
CTD |
PMID:34921933 |
|
NCBI chr17:63,729,743...63,794,021
Ensembl chr17:63,729,780...63,794,018
|
|
G |
Pgam1 |
phosphoglycerate mutase 1 |
increases expression |
ISO |
cupric chloride results in increased expression of PGAM1 protein |
CTD |
PMID:29617964 |
|
NCBI chr 1:240,723,832...240,731,443
Ensembl chr 1:240,723,920...240,738,452
|
|
G |
Pgr |
progesterone receptor |
multiple interactions increases expression |
ISO |
cupric chloride promotes the reaction [Estradiol results in increased expression of PGR mRNA]; cupric chloride promotes the reaction [Estradiol results in increased expression of PGR protein]; Estradiol promotes the reaction [cupric chloride results in increased expression of PGR mRNA]; Estradiol promotes the reaction [cupric chloride results in increased expression of PGR protein]; fulvestrant inhibits the reaction [cupric chloride results in increased expression of PGR mRNA]; fulvestrant inhibits the reaction [cupric chloride results in increased expression of PGR protein] cupric chloride results in increased expression of PGR mRNA; cupric chloride results in increased expression of PGR protein |
CTD |
PMID:12746304 |
|
NCBI chr 8:6,073,216...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Phyhip |
phytanoyl-CoA 2-hydroxylase interacting protein |
decreases expression |
ISO |
cupric chloride results in decreased expression of PHYHIP mRNA |
CTD |
PMID:17211630 |
|
NCBI chr15:45,533,974...45,545,223
Ensembl chr15:45,533,974...45,545,221
|
|
G |
Pitpnc1 |
phosphatidylinositol transfer protein, cytoplasmic 1 |
decreases expression |
ISO |
cupric chloride results in decreased expression of PITPNC1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr10:92,163,558...92,428,971
Ensembl chr10:92,167,196...92,429,297
|
|
G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
increases expression multiple interactions |
ISO |
cupric chloride results in increased expression of PMAIP1 mRNA [prolinedithiocarbamate analog co-treated with cupric chloride] results in increased expression of PMAIP1 protein |
CTD |
PMID:20713136 PMID:21035945 |
|
NCBI chr18:59,986,187...59,990,174
Ensembl chr18:59,986,017...59,992,429
|
|
G |
Pomp |
proteasome maturation protein |
increases expression |
ISO |
cupric chloride results in increased expression of POMP mRNA |
CTD |
PMID:17211630 |
|
NCBI chr12:7,162,098...7,174,737
Ensembl chr12:7,160,714...7,174,715
|
|
G |
Prdx1 |
peroxiredoxin 1 |
increases expression |
ISO |
cupric chloride results in increased expression of PRDX1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 5:130,147,276...130,162,850
Ensembl chr 5:130,147,204...130,162,856
|
|
G |
Prdx3 |
peroxiredoxin 3 |
decreases expression |
ISO |
cupric chloride results in decreased expression of PRDX3 protein |
CTD |
PMID:29617964 |
|
NCBI chr 1:260,001,642...260,014,064
Ensembl chr 1:260,001,637...260,014,111
|
|
G |
Prnp |
prion protein |
multiple interactions increases expression |
ISO EXP |
[NADP co-treated with cupric chloride] promotes the reaction [PRNP protein binds to PRNP protein] bathocuproine sulfonate inhibits the reaction [cupric chloride results in increased expression of PRNP protein] cupric chloride results in increased expression of PRNP mRNA; cupric chloride results in increased expression of PRNP protein |
CTD |
PMID:16148034 PMID:16990274 |
|
NCBI chr 3:119,186,073...119,201,513
Ensembl chr 3:119,177,485...119,203,937
|
|
G |
Proc |
protein C, inactivator of coagulation factors Va and VIIIa |
multiple interactions |
ISO |
ALB protein inhibits the reaction [cupric chloride results in decreased activity of PROC protein]; aspartyl-alanyl-histidyl-lysine inhibits the reaction [cupric chloride results in decreased activity of PROC protein]; cupric chloride binds to and results in decreased activity of PROC protein |
CTD |
PMID:11820775 |
|
NCBI chr18:23,764,367...23,774,816
Ensembl chr18:23,764,368...23,775,133
|
|
G |
Psmb2 |
proteasome 20S subunit beta 2 |
increases expression |
ISO |
cupric chloride results in increased expression of PSMB2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 5:138,970,564...139,002,715
Ensembl chr 5:138,970,533...139,021,137
|
|
G |
Psmb3 |
proteasome 20S subunit beta 3 |
increases expression |
ISO |
cupric chloride results in increased expression of PSMB3 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr10:82,697,425...82,704,521
Ensembl chr10:82,697,425...82,704,521
|
|
G |
Psmb7 |
proteasome 20S subunit beta 7 |
increases expression |
ISO |
cupric chloride results in increased expression of PSMB7 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 3:22,357,777...22,417,748
Ensembl chr 3:22,354,698...22,417,937
|
|
G |
Psmc1 |
proteasome 26S subunit, ATPase 1 |
increases expression |
ISO |
cupric chloride results in increased expression of PSMC1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 6:119,392,833...119,405,233
Ensembl chr 6:119,392,855...119,410,123
|
|
G |
Psmc4 |
proteasome 26S subunit, ATPase 4 |
increases expression |
ISO |
cupric chloride results in increased expression of PSMC4 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:83,349,127...83,357,497
Ensembl chr 1:83,348,592...83,357,494
|
|
G |
Psmd1 |
proteasome 26S subunit, non-ATPase 1 |
increases expression |
ISO |
cupric chloride results in increased expression of PSMD1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 9:86,709,714...86,785,213
Ensembl chr 9:86,709,947...86,785,211
|
|
G |
Psmd11 |
proteasome 26S subunit, non-ATPase 11 |
increases expression |
ISO |
cupric chloride results in increased expression of PSMD11 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr10:65,433,853...65,479,774
Ensembl chr10:65,433,853...65,479,766
|
|
G |
Psmd13 |
proteasome 26S subunit, non-ATPase 13 |
increases expression |
ISO |
cupric chloride results in increased expression of PSMD13 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:195,964,617...195,976,895
Ensembl chr 1:195,964,138...195,976,905
|
|
G |
Psmd14 |
proteasome 26S subunit, non-ATPase 14 |
increases expression |
ISO |
cupric chloride results in increased expression of PSMD14 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 3:46,254,338...46,347,076
Ensembl chr 3:46,254,330...46,347,076
|
|
G |
Psmd2 |
proteasome 26S subunit ubiquitin receptor, non-ATPase 2 |
increases expression |
ISO |
cupric chloride results in increased expression of PSMD2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr11:80,248,364...80,258,991
Ensembl chr11:80,248,364...80,259,043
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases expression |
ISO |
cupric chloride results in increased expression of PTGS2 protein |
CTD |
PMID:23313662 PMID:24170445 |
|
NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptpro |
protein tyrosine phosphatase, receptor type, O |
decreases expression |
ISO |
cupric chloride results in decreased expression of PTPRO mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 4:170,164,071...170,374,790
Ensembl chr 4:170,164,431...170,374,771
|
|
G |
Pura |
purine rich element binding protein A |
decreases expression |
ISO |
cupric chloride results in decreased expression of PURA protein |
CTD |
PMID:29617964 |
|
NCBI chr18:27,884,618...27,905,500
Ensembl chr18:27,884,556...27,905,513
|
|
G |
Qki |
QKI, KH domain containing RNA binding |
increases expression |
ISO |
cupric chloride results in increased expression of QKI mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:50,387,698...50,501,568
Ensembl chr 1:50,387,698...50,498,831
|
|
G |
Ralgapa1 |
Ral GTPase activating protein catalytic subunit alpha 1 |
affects expression |
ISO |
cupric chloride affects the expression of RALGAPA1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 6:72,977,432...73,252,378
Ensembl chr 6:72,977,432...73,252,378
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
cupric chloride results in increased phosphorylation of and affects the localization of RELA protein |
CTD |
PMID:24530511 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rhob |
ras homolog family member B |
decreases expression |
ISO |
cupric chloride results in decreased expression of ARHB mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 6:31,363,752...31,365,926
Ensembl chr 6:31,363,548...31,366,108
|
|
G |
Rnf181 |
ring finger protein 181 |
affects expression |
ISO |
cupric chloride affects the expression of RNF181 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 4:104,414,586...104,421,433
Ensembl chr 4:104,414,605...104,421,309
|
|
G |
Rpl32 |
ribosomal protein L32 |
affects expression |
ISO |
cupric chloride affects the expression of RPL32 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 4:148,864,048...148,867,612
Ensembl chr 4:148,864,044...148,867,612
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
increases phosphorylation |
ISO |
cupric chloride results in increased phosphorylation of RPS6KB1 protein |
CTD |
PMID:32512069 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Rrad |
RRAD, Ras related glycolysis inhibitor and calcium channel regulator |
increases expression |
ISO |
cupric chloride results in increased expression of RRAD mRNA |
CTD |
PMID:17211630 |
|
NCBI chr19:354,184...357,424
Ensembl chr19:354,198...357,417
|
|
G |
Rybp |
RING1 and YY1 binding protein |
affects expression |
ISO |
cupric chloride affects the expression of RYBP mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 4:132,876,361...132,927,580 NCBI chr 4:132,876,260...132,929,075
Ensembl chr 4:132,876,361...132,928,316
|
|
G |
Sbds |
Sbds, ribosome maturation factor |
increases expression |
ISO |
cupric chloride results in increased expression of SBDS mRNA |
CTD |
PMID:17211630 |
|
NCBI chr12:26,420,410...26,429,650
Ensembl chr12:26,420,414...26,429,649
|
|
G |
Scd |
stearoyl-CoA desaturase |
decreases expression |
ISO |
cupric chloride results in decreased expression of SCD mRNA |
CTD |
PMID:34921933 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Sdf2 |
stromal cell derived factor 2 |
increases expression |
ISO |
cupric chloride results in increased expression of SDF2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr10:63,140,563...63,151,038
Ensembl chr10:63,140,563...63,201,109
|
|
G |
Selenok |
selenoprotein K |
increases expression |
ISO |
cupric chloride results in increased expression of SELENOK mRNA |
CTD |
PMID:17211630 |
|
NCBI chr16:5,152,066...5,160,648
Ensembl chr16:5,152,066...5,159,188
|
|
G |
Selenop |
selenoprotein P |
decreases expression |
ISO |
cupric chloride results in decreased expression of SELENOP mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 2:52,498,123...52,508,409
Ensembl chr 2:52,498,339...52,508,852
|
|
G |
Septin4 |
septin 4 |
decreases expression |
ISO |
cupric chloride results in decreased expression of SEPTIN4 protein |
CTD |
PMID:29617964 |
|
NCBI chr10:72,366,729...72,390,764
Ensembl chr10:72,366,873...72,390,768
|
|
G |
Septin8 |
septin 8 |
decreases expression |
ISO |
cupric chloride results in decreased expression of SEPTIN8 protein |
CTD |
PMID:29617964 |
|
NCBI chr10:37,684,639...37,713,704
Ensembl chr10:37,684,639...37,713,174
|
|
G |
Serpinf1 |
serpin family F member 1 |
increases expression |
ISO |
cupric chloride results in increased expression of SERPINF1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
|
|
G |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
multiple interactions |
EXP |
[COMMD1 protein co-treated with zinc chloride co-treated with cupric chloride] results in increased expression of SHANK2 protein |
CTD |
PMID:25007851 |
|
NCBI chr 1:199,146,210...199,590,962
Ensembl chr 1:199,169,429...199,589,394
|
|
G |
Shank3 |
SH3 and multiple ankyrin repeat domains 3 |
multiple interactions |
EXP |
[COMMD1 protein co-treated with zinc chloride co-treated with cupric chloride] results in increased expression of SHANK3 protein |
CTD |
PMID:25007851 |
|
NCBI chr 7:120,568,707...120,630,796
Ensembl chr 7:120,570,402...120,630,374
|
|
G |
Sirt7 |
sirtuin 7 |
increases expression |
ISO |
cupric chloride results in increased expression of SIRT7 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr10:105,896,476...105,903,301
Ensembl chr10:105,896,476...105,903,172
|
|
G |
Slc11a2 |
solute carrier family 11 member 2 |
multiple interactions |
ISO |
cupric chloride inhibits the reaction [SLC11A2 protein results in increased uptake of Iron] |
CTD |
PMID:12220667 |
|
NCBI chr 7:131,503,076...131,540,246
Ensembl chr 7:131,503,081...131,540,145
|
|
G |
Slc13a3 |
solute carrier family 13 member 3 |
decreases expression |
ISO |
cupric chloride results in decreased expression of SLC13A3 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 3:154,141,878...154,204,604
Ensembl chr 3:154,141,872...154,204,606
|
|
G |
Slc22a18 |
solute carrier family 22, member 18 |
increases expression |
ISO |
cupric chloride results in increased expression of SLC22A18 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:198,670,626...198,694,977
Ensembl chr 1:198,671,731...198,694,975
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
increases expression |
ISO |
cupric chloride results in increased expression of SLC2A1 mRNA |
CTD |
PMID:15741220 |
|
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Slc30a1 |
solute carrier family 30 member 1 |
increases expression |
ISO |
cupric chloride results in increased expression of SLC30A1 mRNA |
CTD |
PMID:24343273 |
|
NCBI chr13:103,491,037...103,494,910
Ensembl chr13:103,491,037...103,494,910
|
|
G |
Slc31a1 |
solute carrier family 31 member 1 |
decreases expression multiple interactions |
EXP ISO |
cupric chloride results in decreased expression of SLC31A1 protein SLC31A1 protein results in increased susceptibility to [cupric chloride results in increased abundance of Copper] |
CTD |
PMID:24316150 PMID:24800945 PMID:32278528 |
|
NCBI chr 5:75,814,744...75,844,241
Ensembl chr 5:75,814,743...75,844,228
|
|
G |
Snca |
synuclein alpha |
affects folding |
ISO |
cupric chloride affects the folding of SNCA protein |
CTD |
PMID:11553618 |
|
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions decreases activity decreases expression increases response to substance |
ISO |
Carnosine inhibits the reaction [cupric chloride results in decreased activity of SOD1 protein]; cupric chloride promotes the reaction [COMMD1 protein binds to SOD1 protein]; Pyruvic Acid inhibits the reaction [SOD1 protein mutant form promotes the reaction [cupric chloride results in increased abundance of Peroxides]]; Pyruvic Acid inhibits the reaction [SOD1 protein mutant form results in increased susceptibility to cupric chloride]; SOD1 protein mutant form promotes the reaction [cupric chloride results in increased abundance of Peroxides] cupric chloride results in decreased expression of SOD1 protein |
CTD |
PMID:15812313 PMID:24691167 PMID:29617964 PMID:32745495 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sorbs1 |
sorbin and SH3 domain containing 1 |
decreases expression |
ISO |
cupric chloride results in decreased expression of SORBS1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:239,107,882...239,330,276
Ensembl chr 1:239,108,777...239,330,169
|
|
G |
Spsb1 |
splA/ryanodine receptor domain and SOCS box containing 1 |
increases expression |
ISO |
cupric chloride results in increased expression of SPSB1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 5:160,358,292...160,418,541
Ensembl chr 5:160,358,308...160,418,468
|
|
G |
Sqle |
squalene epoxidase |
decreases expression |
ISO |
cupric chloride results in decreased expression of SQLE mRNA |
CTD |
PMID:34921933 |
|
NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618
|
|
G |
Sqstm1 |
sequestosome 1 |
increases expression multiple interactions |
ISO |
cupric chloride results in increased expression of SQSTM1 mRNA Acetylcysteine inhibits the reaction [cupric chloride results in increased expression of SQSTM1 protein]; PP242 inhibits the reaction [cupric chloride results in increased expression of SQSTM1 protein] |
CTD |
PMID:17211630 PMID:23313662 PMID:32512069 |
|
NCBI chr10:34,525,517...34,536,685
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Srebf2 |
sterol regulatory element binding transcription factor 2 |
decreases expression |
ISO |
cupric chloride results in decreased expression of SREBF2 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr 7:113,663,202...113,720,850
Ensembl chr 7:113,663,202...113,720,848
|
|
G |
St6gal1 |
ST6 beta-galactoside alpha-2,6-sialyltransferase 1 |
decreases expression |
ISO |
cupric chloride results in decreased expression of ST6GAL1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr11:77,526,837...77,653,474
Ensembl chr11:77,526,837...77,653,310
|
|
G |
Stard4 |
StAR-related lipid transfer domain containing 4 |
decreases expression |
ISO |
cupric chloride results in decreased expression of STARD4 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr18:24,814,683...24,830,024
Ensembl chr18:24,817,107...24,830,024
|
|
G |
Stau1 |
staufen double-stranded RNA binding protein 1 |
decreases expression |
ISO |
cupric chloride results in decreased expression of STAU mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 3:155,680,000...155,725,969
Ensembl chr 3:155,680,000...155,725,909
|
|
G |
Stmn1 |
stathmin 1 |
decreases expression |
ISO |
cupric chloride results in decreased expression of STMN1 protein |
CTD |
PMID:29617964 |
|
NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154
|
|
G |
Syn2 |
synapsin II |
decreases expression |
ISO |
cupric chloride results in decreased expression of SYN2 protein |
CTD |
PMID:29617964 |
|
NCBI chr 4:148,178,846...148,347,010
Ensembl chr 4:148,186,270...148,344,192
|
|
G |
Taf7l |
TATA-box binding protein associated factor 7-like |
increases expression |
ISO |
cupric chloride results in increased expression of TAF7L mRNA |
CTD |
PMID:17211630 |
|
NCBI chr X:97,660,222...97,675,241
Ensembl chr X:97,660,222...97,675,023
|
|
G |
Taldo1 |
transaldolase 1 |
increases expression |
ISO |
cupric chloride results in increased expression of TALDO1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:196,493,634...196,503,965
Ensembl chr 1:196,493,589...196,503,974
|
|
G |
Tardbp |
TAR DNA binding protein |
multiple interactions |
ISO |
cupric chloride inhibits the reaction [Paraquat affects the localization of TARDBP protein] |
CTD |
PMID:22879928 |
|
NCBI chr 5:159,050,518...159,062,218
Ensembl chr 5:159,051,799...159,062,055
|
|
G |
Tfdp2 |
transcription factor Dp-2 |
affects expression |
ISO |
cupric chloride affects the expression of TFDP2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 8:96,760,459...96,901,466
Ensembl chr 8:96,760,504...96,896,682
|
|
G |
Tfeb |
transcription factor EB |
decreases expression multiple interactions |
ISO |
cupric chloride results in decreased expression of TFEB mRNA; cupric chloride results in decreased expression of TFEB protein PP242 inhibits the reaction [cupric chloride results in decreased expression of TFEB protein] |
CTD |
PMID:32512069 |
|
NCBI chr 9:13,198,890...13,254,726
Ensembl chr 9:13,198,891...13,254,714
|
|
G |
Tkt |
transketolase |
increases expression |
ISO |
cupric chloride results in increased expression of TKT mRNA |
CTD |
PMID:17211630 |
|
NCBI chr16:5,723,764...5,748,702
Ensembl chr16:5,723,762...5,748,698
|
|
G |
Tmed2 |
transmembrane p24 trafficking protein 2 |
decreases expression |
ISO |
cupric chloride results in decreased expression of TMED2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr12:32,052,542...32,061,596
Ensembl chr12:32,052,543...32,071,903
|
|
G |
Tmem97 |
transmembrane protein 97 |
decreases expression |
ISO |
cupric chloride results in decreased expression of TMEM97 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr10:63,438,228...63,447,311
Ensembl chr10:63,438,222...63,589,730
|
|
G |
Tnf |
tumor necrosis factor |
increases secretion multiple interactions increases expression |
ISO EXP |
cupric chloride results in increased secretion of TNF protein 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [cupric chloride results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [cupric chloride results in increased secretion of TNF protein]; SC 514 inhibits the reaction [cupric chloride results in increased secretion of TNF protein] cupric chloride inhibits the reaction [TNF protein results in increased secretion of IL6 protein] cupric chloride results in increased expression of TNF protein |
CTD |
PMID:22954531 PMID:23285694 PMID:23313662 PMID:24170445 PMID:24530511 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
affects expression multiple interactions decreases expression increases expression |
ISO |
cupric chloride affects the expression of TRP53 mRNA [cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of TP53 protein; CAT protein inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of TP53 protein]; Ethanol inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of TP53 protein]; Mannitol inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of TP53 protein]; neocuproine inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of TP53 protein]; Thiourea inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of TP53 protein] cupric chloride results in decreased expression of TRP53 protein cupric chloride results in increased expression of TRP53 protein |
CTD |
PMID:23313662 PMID:24170445 PMID:29803612 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tp73 |
tumor protein p73 |
affects expression increases expression |
ISO |
cupric chloride affects the expression of TRP73 protein cupric chloride results in increased expression of TRP73 protein |
CTD |
PMID:23313662 PMID:24170445 |
|
NCBI chr 5:164,621,377...164,703,958
Ensembl chr 5:164,621,377...164,681,128
|
|
G |
Tpm1 |
tropomyosin 1 |
increases expression |
ISO |
cupric chloride results in increased expression of TPM1 protein |
CTD |
PMID:29617964 |
|
NCBI chr 8:67,635,479...67,662,330
Ensembl chr 8:67,635,479...67,662,802
|
|
G |
Tppp |
tubulin polymerization promoting protein |
increases expression |
ISO |
cupric chloride results in increased expression of TPPP protein |
CTD |
PMID:29617964 |
|
NCBI chr 1:29,257,111...29,281,134
Ensembl chr 1:29,261,255...29,281,134
|
|
G |
Traf5 |
TNF receptor-associated factor 5 |
increases expression |
ISO |
cupric chloride results in increased expression of TRAF5 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr13:103,569,944...103,618,756
Ensembl chr13:103,572,314...103,618,709
|
|
G |
Trib3 |
tribbles pseudokinase 3 |
increases expression |
ISO |
cupric chloride results in increased expression of TRIB3 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
|
|
G |
Tsc22d3 |
TSC22 domain family, member 3 |
multiple interactions |
ISO |
[cupric chloride results in increased abundance of Copper] inhibits the reaction [Hydrocortisone results in increased expression of TSC22D3 mRNA] |
CTD |
PMID:29957541 |
|
NCBI chr X:104,217,898...104,277,935
Ensembl chr X:104,217,925...104,276,861
|
|
G |
Txn1 |
thioredoxin 1 |
increases expression |
ISO |
cupric chloride results in increased expression of TXN mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
|
|
G |
Txnl1 |
thioredoxin-like 1 |
increases expression |
ISO |
cupric chloride results in increased expression of TXNL1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr18:57,125,362...57,155,167
Ensembl chr18:57,125,369...57,165,266
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
increases expression |
ISO |
cupric chloride results in increased expression of TXNRD1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Tyr |
tyrosinase |
multiple interactions |
ISO |
cupric chloride inhibits the reaction [bathocuproine sulfonate inhibits the reaction [ATP7A protein results in increased activity of TYR protein]] |
CTD |
PMID:11092760 |
|
NCBI chr 1:141,115,036...141,210,207
Ensembl chr 1:141,115,036...141,210,207
|
|
G |
Uba1 |
ubiquitin-like modifier activating enzyme 1 |
multiple interactions |
ISO |
cupric chloride promotes the reaction [Dimethyldithiocarbamate results in decreased activity of and results in decreased ubiquitination of UBA1 protein]; cupric chloride results in decreased activity of and results in decreased ubiquitination of UBA1 protein |
CTD |
PMID:25714994 |
|
NCBI chr X:1,508,700...1,530,677
Ensembl chr X:1,508,666...1,530,636
|
|
G |
Ubc |
ubiquitin C |
increases expression |
ISO |
cupric chloride results in increased expression of UBC mRNA |
CTD |
PMID:17211630 |
|
NCBI chr12:31,238,889...31,243,924
Ensembl chr12:31,239,152...31,243,925
|
|
G |
Ubr5 |
ubiquitin protein ligase E3 component n-recognin 5 |
increases expression |
ISO |
cupric chloride results in increased expression of UBR5 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 7:69,116,758...69,224,490
Ensembl chr 7:69,116,761...69,224,903
|
|
G |
Uchl1 |
ubiquitin C-terminal hydrolase L1 |
increases expression |
ISO |
cupric chloride results in increased expression of UCHL1 protein |
CTD |
PMID:29617964 |
|
NCBI chr14:41,485,033...41,495,590
Ensembl chr14:41,485,031...41,495,590
|
|
G |
Ufd1 |
ubiquitin recognition factor in ER associated degradation 1 |
increases expression |
ISO |
cupric chloride results in increased expression of UFD1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr11:82,161,618...82,185,107
Ensembl chr11:82,161,619...82,185,087
|
|
G |
Unc79 |
unc-79 homolog, NALCN channel complex subunit |
decreases expression |
ISO |
cupric chloride results in decreased expression of UNC79 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr 6:122,082,369...122,327,641
Ensembl chr 6:122,080,308...122,327,591
|
|
G |
Unkl |
unk like zinc finger |
increases expression |
ISO |
cupric chloride results in increased expression of UNKL mRNA |
CTD |
PMID:17211630 |
|
NCBI chr10:14,206,125...14,252,226
Ensembl chr10:14,206,189...14,252,225
|
|
G |
Uqcrc1 |
ubiquinol-cytochrome c reductase core protein 1 |
increases expression |
ISO |
cupric chloride results in increased expression of UQCRC1 protein |
CTD |
PMID:29617964 |
|
NCBI chr 8:109,589,735...109,601,481
Ensembl chr 8:109,589,706...109,601,480
|
|
G |
Uqcrh |
ubiquinol-cytochrome c reductase hinge protein |
decreases expression |
ISO |
cupric chloride results in decreased expression of UQCRH protein |
CTD |
PMID:29617964 |
|
NCBI chr 5:129,545,978...129,554,173
Ensembl chr 5:129,545,984...129,554,242
|
|
G |
Utp11 |
UTP11, small subunit processome component |
increases expression |
ISO |
cupric chloride results in increased expression of UTP11 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 5:136,931,279...136,946,164
Ensembl chr 5:136,931,008...136,946,191
|
|
G |
Vdac1 |
voltage-dependent anion channel 1 |
increases expression |
ISO |
cupric chloride results in increased expression of VDAC1 protein |
CTD |
PMID:29617964 |
|
NCBI chr10:36,532,306...36,559,642
Ensembl chr10:36,532,244...36,559,640
|
|
G |
Vdac2 |
voltage-dependent anion channel 2 |
increases expression |
ISO |
cupric chloride results in increased expression of VDAC2 protein |
CTD |
PMID:29617964 |
|
NCBI chr15:2,462,877...2,476,802
Ensembl chr15:2,463,056...2,476,553
|
|
G |
Vegfa |
vascular endothelial growth factor A |
increases expression |
ISO |
cupric chloride results in increased expression of VEGFA mRNA |
CTD |
PMID:15741220 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vps13b |
vacuolar protein sorting 13 homolog B |
affects expression |
ISO |
cupric chloride affects the expression of VPS13B mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 7:66,557,862...67,128,429
Ensembl chr 7:66,558,471...67,128,429
|
|
G |
Wdr74 |
WD repeat domain 74 |
affects expression |
ISO |
cupric chloride affects the expression of WDR74 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:205,631,769...205,636,563
Ensembl chr 1:205,631,824...205,636,563
|
|
G |
Zbtb5 |
zinc finger and BTB domain containing 5 |
decreases expression |
ISO |
cupric chloride results in decreased expression of ZBTB5 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr 5:59,244,132...59,265,461
Ensembl chr 5:59,243,307...59,265,426
|
|
G |
Zfp12 |
zinc finger protein 12 |
increases expression |
ISO |
cupric chloride results in increased expression of ZNF12 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr12:11,316,971...11,330,498
Ensembl chr12:11,316,872...11,330,558
|
|
G |
Znrd2 |
zinc ribbon domain containing 2 |
increases expression |
ISO |
cupric chloride results in increased expression of ZNRD2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:203,017,682...203,019,465
Ensembl chr 1:203,017,682...203,019,465
|
|
G |
Zswim6 |
zinc finger, SWIM-type containing 6 |
affects expression |
ISO |
cupric chloride affects the expression of ZSWIM6 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 2:39,211,131...39,378,877
Ensembl chr 2:39,212,949...39,378,924
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases activity |
ISO |
Trifluoperazine results in increased activity of ABCB1 protein |
CTD |
PMID:2900677 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions increases activity decreases expression |
EXP ISO |
energostim inhibits the reaction [Trifluoperazine results in decreased expression of ACHE protein] Trifluoperazine results in increased activity of ACHE protein |
CTD |
PMID:15232633 PMID:29614332 |
|
NCBI chr12:19,407,359...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
EXP ISO |
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of AKT1 protein]; Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of AKT1 protein] |
CTD |
PMID:19233221 PMID:21544200 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Atp6v1h |
ATPase H+ transporting V1 subunit H |
multiple interactions |
ISO |
[PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of ATP6V1H mRNA |
CTD |
PMID:28366621 |
|
NCBI chr 5:14,379,029...14,484,703
Ensembl chr 5:14,378,257...14,537,962
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
Trifluoperazine results in increased expression of BAX protein |
CTD |
PMID:21475906 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression |
ISO |
Trifluoperazine results in decreased expression of BCL2 protein |
CTD |
PMID:21475906 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
multiple interactions |
EXP |
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of CAMK2A protein] |
CTD |
PMID:19233221 |
|
NCBI chr18:54,378,642...54,441,120
Ensembl chr18:54,378,784...54,438,994
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
EXP ISO |
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased cleavage of and results in increased activity of CASP3 protein] |
CTD |
PMID:21544200 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cd44 |
CD44 molecule (Indian blood group) |
multiple interactions |
ISO |
Trifluoperazine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CD44 protein] |
CTD |
PMID:9929743 |
|
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
multiple interactions |
EXP ISO |
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of EIF4EBP1 protein] |
CTD |
PMID:21544200 |
|
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
|
|
G |
Fmo2 |
flavin containing dimethylaniline monoxygenase 2 |
increases oxidation |
ISO |
FMO2 protein results in increased oxidation of Trifluoperazine |
CTD |
PMID:26062974 |
|
NCBI chr13:75,221,149...75,244,377
Ensembl chr13:75,224,402...75,244,308
|
|
G |
Gabbr1 |
gamma-aminobutyric acid type B receptor subunit 1 |
multiple interactions |
ISO |
Trifluoperazine inhibits the reaction [2,6-di-tert-butyl-4-(3-hydroxy-2,2-dimethylpropyl)phenol promotes the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]]] |
CTD |
PMID:15627515 |
|
NCBI chr20:1,464,534...1,494,114
Ensembl chr20:1,464,534...1,493,994
|
|
G |
Gabbr2 |
gamma-aminobutyric acid type B receptor subunit 2 |
multiple interactions |
ISO |
Trifluoperazine inhibits the reaction [2,6-di-tert-butyl-4-(3-hydroxy-2,2-dimethylpropyl)phenol promotes the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]]] |
CTD |
PMID:15627515 |
|
NCBI chr 5:60,947,517...61,288,104
Ensembl chr 5:60,947,526...61,288,104
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
decreases expression |
ISO |
Trifluoperazine results in decreased expression of HIF1A protein |
CTD |
PMID:18822394 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Il12b |
interleukin 12B |
multiple interactions |
ISO |
Trifluoperazine inhibits the reaction [Hydrogen Peroxide results in decreased expression of IL12B protein] |
CTD |
PMID:16249388 |
|
NCBI chr10:28,888,832...28,903,796
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
multiple interactions |
ISO |
Trifluoperazine inhibits the reaction [KCNH2 protein results in increased transport of Thallium] |
CTD |
PMID:21158687 |
|
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
|
|
G |
Kcnn2 |
potassium calcium-activated channel subfamily N member 2 |
decreases activity |
EXP |
Trifluoperazine results in decreased activity of KCNN2 protein |
CTD |
PMID:10915830 |
|
NCBI chr18:37,817,966...38,258,347
Ensembl chr18:37,817,957...38,258,347
|
|
G |
Lamp1 |
lysosomal-associated membrane protein 1 |
multiple interactions |
ISO |
[PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of LAMP1 mRNA |
CTD |
PMID:28366621 |
|
NCBI chr16:76,355,982...76,380,700
Ensembl chr16:76,355,984...76,381,883
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
EXP ISO |
Trifluoperazine inhibits the reaction [[Norepinephrine co-treated with Timolol] results in increased activity of MAPK1 protein]; Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Trifluoperazine inhibits the reaction [Dinoprost results in increased activity of MAPK1 protein] |
CTD |
PMID:11914123 PMID:21544200 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
multiple interactions |
ISO EXP |
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK14 protein] |
CTD |
PMID:21544200 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
EXP ISO |
Trifluoperazine inhibits the reaction [[Norepinephrine co-treated with Timolol] results in increased activity of MAPK3 protein]; Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Trifluoperazine inhibits the reaction [Dinoprost results in increased activity of MAPK3 protein] |
CTD |
PMID:11914123 PMID:21544200 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO EXP |
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK8 protein] |
CTD |
PMID:21544200 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
multiple interactions |
ISO EXP |
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein] |
CTD |
PMID:21544200 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Mt1 |
metallothionein 1 |
increases expression |
EXP |
Trifluoperazine results in increased expression of MT1A mRNA |
CTD |
PMID:8128501 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
multiple interactions |
EXP ISO |
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MTOR protein] |
CTD |
PMID:21544200 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Myl9 |
myosin light chain 9 |
multiple interactions |
EXP |
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MYL9 protein]; Trifluoperazine inhibits the reaction [Ionomycin results in increased phosphorylation of MYL9 protein] |
CTD |
PMID:19233221 |
|
NCBI chr 3:145,281,943...145,288,333
Ensembl chr 3:145,281,937...145,288,333
|
|
G |
Nefl |
neurofilament light chain |
multiple interactions |
EXP |
Trifluoperazine inhibits the reaction [Rotenone results in decreased expression of NEFL mRNA] |
CTD |
PMID:31969611 |
|
NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
decreases activity |
ISO |
Trifluoperazine results in decreased activity of NR3C1 protein |
CTD |
PMID:7887964 |
|
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
EXP ISO |
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased cleavage of PARP1 protein] |
CTD |
PMID:21544200 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pink1 |
PTEN induced kinase 1 |
multiple interactions |
ISO |
[PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of ATP6V1H mRNA; [PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of LAMP1 mRNA; [PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of TFEB mRNA; PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]; Trifluoperazine affects the reaction [PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] affects the localization of TFEB protein]] |
CTD |
PMID:28366621 |
|
NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635
|
|
G |
Prkn |
parkin RBR E3 ubiquitin protein ligase |
affects localization multiple interactions |
ISO |
Trifluoperazine affects the localization of PRKN protein PRKN protein affects the reaction [Trifluoperazine affects the localization of PRKN protein] |
CTD |
PMID:28366621 |
|
NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
|
|
G |
Prl |
prolactin |
increases expression |
ISO |
Trifluoperazine results in increased expression of PRL protein |
CTD |
PMID:2136057 |
|
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
|
|
G |
Rel |
REL proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
Trifluoperazine inhibits the reaction [Hydrogen Peroxide results in decreased localization of REL protein] |
CTD |
PMID:16249388 |
|
NCBI chr14:97,690,105...97,721,194
Ensembl chr14:97,695,161...97,720,892
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
multiple interactions |
EXP ISO |
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of RPS6KB1 protein] |
CTD |
PMID:21544200 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Slc5a6 |
solute carrier family 5 member 6 |
multiple interactions |
ISO |
Trifluoperazine inhibits the reaction [SLC5A6 protein results in increased transport of Biotin] |
CTD |
PMID:15561972 |
|
NCBI chr 6:25,319,187...25,331,713
Ensembl chr 6:25,320,442...25,331,712
|
|
G |
Tfeb |
transcription factor EB |
multiple interactions |
ISO |
[PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of TFEB mRNA; Trifluoperazine affects the reaction [PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] affects the localization of TFEB protein]] |
CTD |
PMID:28366621 |
|
NCBI chr 9:13,198,890...13,254,726
Ensembl chr 9:13,198,891...13,254,714
|
|
G |
Tnfsf11 |
TNF superfamily member 11 |
decreases activity |
ISO |
Trifluoperazine results in decreased activity of TNFSF11 |
CTD |
PMID:21869564 |
|
NCBI chr15:53,674,990...53,705,171
Ensembl chr15:53,673,877...53,705,445
|
|
G |
Ugt1a5 |
UDP glucuronosyltransferase family 1 member A5 |
increases glucuronidation multiple interactions increases activity |
ISO |
UGT1A4 protein results in increased glucuronidation of Trifluoperazine Finasteride inhibits the reaction [UGT1A4 protein results in increased glucuronidation of Trifluoperazine]; hecogenin inhibits the reaction [UGT1A4 protein results in increased glucuronidation of Trifluoperazine]; licochalcone A inhibits the reaction [Trifluoperazine results in increased activity of UGT1A4 protein]; Trifluoperazine inhibits the reaction [UGT1A4 protein results in increased glucuronidation of afloqualone] |
CTD |
PMID:15135306 PMID:15475412 PMID:25393417 PMID:25448279 PMID:26875642 PMID:33290829 More...
|
|
NCBI chr 9:88,762,250...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ABCB1 mRNA] zinc chloride inhibits the reaction [Doxorubicin results in increased expression of ABCB1 mRNA] |
CTD |
PMID:19714248 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb6 |
ATP binding cassette subfamily B member 6 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ABCB6 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 9:76,668,554...76,677,263
Ensembl chr 9:76,668,554...76,676,924
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions |
EXP |
[zinc chloride results in increased abundance of Zinc] inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased activity of ACHE protein]; zinc chloride inhibits the reaction [Malathion results in decreased activity of ACHE protein] |
CTD |
PMID:19429256 PMID:29233033 |
|
NCBI chr12:19,407,359...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Aco2 |
aconitase 2 |
multiple interactions |
ISO |
[Citric Acid co-treated with zinc chloride] results in decreased activity of ACO2 protein |
CTD |
PMID:16624386 |
|
NCBI chr 7:113,385,677...113,428,794
Ensembl chr 7:113,385,646...113,428,261
|
|
G |
Actb |
actin, beta |
multiple interactions |
ISO |
[zinc chloride results in increased abundance of Zinc] which results in increased expression of ACTB mRNA |
CTD |
PMID:31588059 |
|
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
|
|
G |
Adam2 |
ADAM metallopeptidase domain 2 |
decreases expression |
ISO |
zinc chloride results in decreased expression of ADAM2 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr15:40,242,783...40,284,025
Ensembl chr15:40,242,783...40,283,952
|
|
G |
Adgre1 |
adhesion G protein-coupled receptor E1 |
multiple interactions increases expression |
ISO |
N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [zinc chloride results in increased expression of ADGRE1 protein]; NCF1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of ADGRE1 protein]; PARP1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of ADGRE1 protein] |
CTD |
PMID:18509044 |
|
NCBI chr 9:2,242,476...2,398,000
Ensembl chr 9:2,242,474...2,398,000
|
|
G |
Adm |
adrenomedullin |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ADM mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Adora1 |
adenosine A1 receptor |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [N(6)-cyclohexyladenosine binds to ADORA1 protein] |
CTD |
PMID:10413299 |
|
NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801
|
|
G |
Afp |
alpha-fetoprotein |
decreases expression |
ISO |
zinc chloride results in decreased expression of AFP mRNA |
CTD |
PMID:18947441 |
|
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
|
|
G |
Ago2 |
argonaute RISC catalytic component 2 |
multiple interactions |
ISO |
[Clioquinol co-treated with zinc chloride] results in decreased expression of AGO2 mRNA; [Clioquinol co-treated with zinc chloride] results in decreased expression of AGO2 protein |
CTD |
PMID:22415087 |
|
NCBI chr 7:105,018,202...105,105,120
Ensembl chr 7:105,029,120...105,104,974
|
|
G |
Ak4 |
adenylate kinase 4 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of AK4 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 5:116,039,222...116,099,064
Ensembl chr 5:116,039,616...116,098,618
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
increases phosphorylation multiple interactions |
ISO |
zinc chloride results in increased phosphorylation of AKT1 protein wortmannin inhibits the reaction [zinc chloride results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:11340092 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alad |
aminolevulinate dehydratase |
multiple interactions |
ISO EXP |
[zinc chloride inhibits the reaction [Mercuric Chloride results in decreased activity of ALAD protein]] which affects the abundance of Mercury; zinc chloride inhibits the reaction [Mercuric Chloride results in decreased activity of ALAD protein] lead nitrate inhibits the reaction [zinc chloride promotes the reaction [Dithiothreitol results in increased activity of ALAD protein]]; triethyllead acetate inhibits the reaction [zinc chloride promotes the reaction [Dithiothreitol results in increased activity of ALAD protein]]; zinc chloride promotes the reaction [Dithiothreitol results in increased activity of ALAD protein] zinc chloride inhibits the reaction [Mercuric Chloride results in decreased activity of ALAD protein]; zinc chloride inhibits the reaction [Mercuric Chloride results in increased activity of ALAD protein] |
CTD |
PMID:2061546 PMID:14615064 PMID:22413763 PMID:24619859 PMID:24679358 |
|
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
|
|
G |
Aldoa |
aldolase, fructose-bisphosphate A |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ALDOA mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
|
|
G |
Aldoc |
aldolase, fructose-bisphosphate C |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ALDOC mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
multiple interactions increases activity |
ISO EXP |
[zinc chloride deficiency co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in decreased expression of ALPL mRNA zinc chloride results in increased activity of ALPL protein Cadmium inhibits the reaction [zinc chloride results in increased activity of ALPL protein]; zinc chloride inhibits the reaction [Cadmium results in decreased activity of ALPL protein] |
CTD |
PMID:19913120 PMID:26214600 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Ang |
angiogenin |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ANG mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr15:24,317,733...24,323,361
|
|
G |
Angptl4 |
angiopoietin-like 4 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ANGPTL4 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
|
|
G |
Ankrd37 |
ankyrin repeat domain 37 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ANKRD37 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr16:46,269,025...46,271,971
Ensembl chr16:46,268,443...46,271,963
|
|
G |
Ankzf1 |
ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ANKZF1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 9:76,688,223...76,695,141
Ensembl chr 9:76,688,194...76,696,469
|
|
G |
Ar |
androgen receptor |
multiple interactions |
EXP |
Androgens inhibits the reaction [zinc chloride inhibits the reaction [Androgens binds to AR protein]]; Dithiothreitol inhibits the reaction [zinc chloride inhibits the reaction [Androgens binds to AR protein]]; zinc chloride inhibits the reaction [Androgens binds to AR protein] |
CTD |
PMID:6323860 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arg2 |
arginase 2 |
increases expression |
ISO |
zinc chloride results in increased expression of ARG2 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378
|
|
G |
Arrb2 |
arrestin, beta 2 |
affects localization |
ISO |
zinc chloride affects the localization of ARRB2 protein |
CTD |
PMID:16959833 |
|
NCBI chr10:55,146,887...55,154,854
Ensembl chr10:55,146,818...55,154,850
|
|
G |
Atf2 |
activating transcription factor 2 |
multiple interactions |
ISO |
[[cupric chloride results in increased abundance of Copper] co-treated with [zinc chloride results in increased abundance of Zinc]] results in increased phosphorylation of ATF2 protein; pyrazolanthrone inhibits the reaction [[[cupric chloride results in increased abundance of Copper] co-treated with [zinc chloride results in increased abundance of Zinc]] results in increased phosphorylation of ATF2 protein] |
CTD |
PMID:30768131 |
|
NCBI chr 3:58,718,323...58,795,280
Ensembl chr 3:58,718,332...58,795,236
|
|
G |
Atf4 |
activating transcription factor 4 |
decreases expression |
ISO |
zinc chloride results in decreased expression of ATF4 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Atp6v1b2 |
ATPase H+ transporting V1 subunit B2 |
decreases expression |
ISO |
zinc chloride results in decreased expression of ATP6V1B2 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr16:20,617,515...20,641,651
Ensembl chr16:20,617,518...20,641,745
|
|
G |
Atp7b |
ATPase copper transporting beta |
decreases expression increases expression |
ISO |
zinc chloride results in decreased expression of ATP7B mRNA zinc chloride results in increased expression of ATP7B mRNA |
CTD |
PMID:18947441 |
|
NCBI chr16:69,952,286...70,024,404
Ensembl chr16:69,951,778...70,023,636
|
|
G |
Bag3 |
BAG cochaperone 3 |
increases expression multiple interactions |
ISO |
zinc chloride results in increased expression of BAG3 mRNA zinc chloride results in increased expression of and affects the localization of BAG3 protein |
CTD |
PMID:12706811 PMID:16870260 |
|
NCBI chr 1:183,103,038...183,126,862
Ensembl chr 1:183,102,871...183,126,858
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
ISO EXP |
[Citric Acid co-treated with zinc chloride] results in increased expression of BAX protein zinc chloride affects the reaction [Cadmium Chloride results in increased expression of BAX protein] zinc chloride promotes the reaction [Doxorubicin results in increased expression of BAX mRNA] |
CTD |
PMID:16624386 PMID:19714248 PMID:28390674 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbc3 |
Bcl-2 binding component 3 |
multiple interactions |
ISO |
zinc chloride promotes the reaction [Doxorubicin results in increased expression of BBC3 mRNA] |
CTD |
PMID:19714248 |
|
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
ISO |
[Citric Acid co-treated with zinc chloride] results in decreased expression of BCL2 protein; zinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of BCL2 mRNA]; zinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of BCL2 protein]; zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of BCL2 mRNA] zinc chloride inhibits the reaction [Doxorubicin results in increased expression of BCL2 mRNA] |
CTD |
PMID:16624386 PMID:17786326 PMID:19714248 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2a1 |
BCL2-related protein A1 |
increases expression |
ISO |
zinc chloride results in increased expression of BCL2A1 mRNA |
CTD |
PMID:21540303 |
|
NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions |
ISO |
[Citric Acid co-treated with zinc chloride] results in decreased expression of BCL2L1 protein |
CTD |
PMID:16624386 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions |
EXP |
zinc chloride affects the reaction [Cadmium Chloride affects the expression of BDNF mRNA] |
CTD |
PMID:29548726 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Bglap |
bone gamma-carboxyglutamate protein |
multiple interactions |
ISO |
[zinc chloride co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in increased expression of BGLAP mRNA; [zinc chloride deficiency co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in decreased expression of BGLAP mRNA |
CTD |
PMID:19913120 |
|
NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
|
|
G |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of BHLHE40 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 4:141,618,453...141,624,154
Ensembl chr 4:141,618,476...141,624,774
|
|
G |
Bnip3l |
BCL2 interacting protein 3 like |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of BNIP3L mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr15:41,174,594...41,197,730
Ensembl chr15:41,174,594...41,197,803
|
|
G |
Bop1 |
BOP1 ribosomal biogenesis factor |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of BOP1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 7:108,172,062...108,195,875
Ensembl chr 7:108,172,066...108,195,931
|
|
G |
C3 |
complement C3 |
increases expression |
ISO |
zinc chloride results in increased expression of C3 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
Cacna1h |
calcium voltage-gated channel subunit alpha1 H |
decreases activity multiple interactions |
ISO |
zinc chloride results in decreased activity of CACNA1H protein zinc chloride inhibits the reaction [Vincristine results in increased expression of CACNA1H protein] |
CTD |
PMID:34286406 |
|
NCBI chr10:14,390,104...14,448,204
Ensembl chr10:14,390,113...14,448,376
|
|
G |
Cald1 |
caldesmon 1 |
increases expression |
ISO |
zinc chloride results in increased expression of CALD1 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 4:63,265,781...63,446,936
Ensembl chr 4:63,265,942...63,446,932
|
|
G |
Car13 |
carbonic anhydrase 13 |
increases expression |
ISO |
zinc chloride results in increased expression of CAR13 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 2:86,928,401...86,959,525
Ensembl chr 2:86,928,383...86,959,525
|
|
G |
Car9 |
carbonic anhydrase 9 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of CA9 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 5:57,763,234...57,769,838
Ensembl chr 5:57,763,206...57,769,838
|
|
G |
Casp12 |
caspase 12 |
multiple interactions |
ISO |
[Citric Acid co-treated with zinc chloride] results in increased activity of CASP12 protein |
CTD |
PMID:16624386 |
|
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
[Citric Acid co-treated with zinc chloride] results in increased activity of CASP3 protein |
CTD |
PMID:16624386 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [Cadmium Chloride results in increased expression of CASP9 mRNA] |
CTD |
PMID:28390674 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions increases expression increases activity |
EXP ISO |
zinc chloride inhibits the reaction [Cadmium Chloride results in decreased activity of CAT protein]; zinc chloride inhibits the reaction [Malathion results in decreased activity of CAT protein] zinc chloride results in increased expression of CAT mRNA zinc chloride results in increased activity of CAT protein |
CTD |
PMID:9330853 PMID:19429256 PMID:23726800 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
increases expression |
ISO |
zinc chloride results in increased expression of CCL11 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
|
|
G |
Ccl17 |
C-C motif chemokine ligand 17 |
decreases expression |
ISO |
zinc chloride results in decreased expression of CCL17 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr19:10,202,317...10,203,768
Ensembl chr19:10,202,128...10,203,819
|
|
G |
Ccl19 |
C-C motif chemokine ligand 19 |
decreases expression |
ISO |
zinc chloride results in decreased expression of CCL19 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr 5:56,963,364...56,965,308
Ensembl chr 5:56,963,364...56,965,308
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
increases expression |
ISO |
zinc chloride results in increased expression of CCL20 mRNA |
CTD |
PMID:19428942 PMID:21540303 PMID:27427241 |
|
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
|
|
G |
Ccl24 |
C-C motif chemokine ligand 24 |
decreases expression |
ISO |
zinc chloride results in decreased expression of CCL24 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr12:21,100,835...21,104,832
Ensembl chr12:21,100,835...21,104,893
|
|
G |
Ccl26 |
C-C motif chemokine ligand 26 |
increases expression |
ISO |
zinc chloride results in increased expression of CCL26 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr12:21,109,384...21,114,336
Ensembl chr12:21,109,421...21,114,335
|
|
G |
Ccl9 |
C-C motif chemokine ligand 9 |
decreases expression |
ISO |
zinc chloride results in decreased expression of CCL15 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr10:68,366,486...68,371,408
Ensembl chr10:68,366,487...68,371,369
|
|
G |
Ccnb1 |
cyclin B1 |
increases expression |
ISO |
zinc chloride results in increased expression of CCNB1 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccng1 |
cyclin G1 |
multiple interactions |
ISO |
zinc chloride affects the reaction [Cadmium Chloride results in increased expression of CCNG1 mRNA] |
CTD |
PMID:16842966 |
|
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
|
|
G |
Ccng2 |
cyclin G2 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of CCNG2 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
|
|
G |
Ccr6 |
C-C motif chemokine receptor 6 |
decreases expression |
ISO |
zinc chloride results in decreased expression of CCR6 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr 1:52,474,477...52,508,301
Ensembl chr 1:52,474,168...52,498,603
|
|
G |
Ccr8 |
C-C motif chemokine receptor 8 |
decreases expression |
ISO |
zinc chloride results in decreased expression of CCR8 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr 8:119,826,332...119,828,292
Ensembl chr 8:119,826,568...119,827,629
|
|
G |
Cd86 |
CD86 molecule |
decreases expression |
ISO |
zinc chloride results in decreased expression of CD86 protein |
CTD |
PMID:24284788 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Cd9 |
CD9 molecule |
increases expression |
ISO |
zinc chloride results in increased expression of CD9 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222
|
|
G |
Cdh17 |
cadherin 17 |
decreases expression |
ISO |
zinc chloride results in decreased expression of CDH17 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr 5:25,262,820...25,314,884
Ensembl chr 5:25,262,758...25,314,884
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions |
ISO |
[Citric Acid co-treated with zinc chloride] results in increased expression of CDKN1A protein |
CTD |
PMID:16624386 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
decreases expression |
ISO |
zinc chloride results in decreased expression of CDKN1B mRNA |
CTD |
PMID:21540303 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B |
decreases expression |
ISO |
zinc chloride results in decreased expression of CDKN2B mRNA |
CTD |
PMID:21540303 |
|
NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:104,010,680...104,019,050
|
|
G |
Cdr1 |
cerebellar degeneration related 1 |
decreases expression |
ISO |
zinc chloride results in decreased expression of CDR1 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr X:139,590,816...139,594,141
|
|
G |
Ceacam6 |
CEA cell adhesion molecule 6 |
increases expression |
ISO |
zinc chloride results in increased expression of CEACAM6 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr 1:80,416,531...80,434,668
Ensembl chr 1:80,416,531...80,434,668
|
|
G |
Cftr |
CF transmembrane conductance regulator |
increases expression |
ISO |
zinc chloride results in increased expression of CFTR mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
|
|
G |
Chek1 |
checkpoint kinase 1 |
increases expression |
ISO |
zinc chloride results in increased expression of CHEK1 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
|
|
G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of CITED2 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
multiple interactions |
ISO |
[zinc chloride deficiency co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in decreased expression of COL1A1 mRNA |
CTD |
PMID:19913120 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Commd1 |
copper metabolism domain containing 1 |
multiple interactions |
EXP |
[COMMD1 protein co-treated with zinc chloride co-treated with cupric chloride] results in increased expression of SHANK2 protein; [COMMD1 protein co-treated with zinc chloride co-treated with cupric chloride] results in increased expression of SHANK3 protein |
CTD |
PMID:25007851 |
|
NCBI chr14:96,880,463...96,984,494
Ensembl chr14:96,880,463...96,984,501
|
|
G |
Cox17 |
cytochrome c oxidase copper chaperone COX17 |
decreases expression |
ISO |
zinc chloride results in decreased expression of COX17 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr11:62,400,733...62,406,507
|
|
G |
Cp |
ceruloplasmin |
increases expression |
ISO |
zinc chloride results in increased expression of CP mRNA |
CTD |
PMID:18947441 |
|
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
|
|
G |
Cps1 |
carbamoyl-phosphate synthase 1 |
increases expression |
ISO |
zinc chloride results in increased expression of CPS1 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 9:68,614,153...68,737,037
Ensembl chr 9:68,614,153...68,737,033
|
|
G |
Crp |
C-reactive protein |
increases expression |
ISO |
zinc chloride results in increased expression of CRP mRNA |
CTD |
PMID:19428942 |
|
NCBI chr13:85,131,635...85,175,179
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Csf2 |
colony stimulating factor 2 |
increases expression multiple interactions |
ISO |
zinc chloride results in increased expression of CSF2 mRNA zinc chloride results in increased expression of CSF2 protein N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [zinc chloride results in increased expression of CSF2 protein]; NCF1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of CSF2 protein]; PARP1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of CSF2 protein] |
CTD |
PMID:18509044 PMID:21540303 PMID:27427241 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Csrp2 |
cysteine and glycine-rich protein 2 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of CSRP2 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 7:46,349,109...46,367,743
Ensembl chr 7:46,348,686...46,367,745
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
increases expression |
ISO |
zinc chloride results in increased expression of CXCL1 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl11 |
C-X-C motif chemokine ligand 11 |
increases expression |
ISO |
zinc chloride results in increased expression of CXCL11 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271
|
|
G |
Cxcl13 |
C-X-C motif chemokine ligand 13 |
decreases expression |
ISO |
zinc chloride results in decreased expression of CXCL13 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr14:13,608,894...13,613,965
Ensembl chr14:13,608,902...13,613,933
|
|
G |
Cxcl14 |
C-X-C motif chemokine ligand 14 |
increases expression |
ISO |
zinc chloride results in increased expression of CXCL14 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr17:8,317,933...8,325,956
Ensembl chr17:8,317,933...8,324,839
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
increases expression |
ISO |
zinc chloride results in increased expression of CXCL1 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr14:17,270,146...17,289,458
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cxcl6 |
C-X-C motif chemokine ligand 6 |
decreases expression |
ISO |
zinc chloride results in decreased expression of CXCL6 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr14:17,310,089...17,312,303
Ensembl chr14:17,310,426...17,313,093
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases stability multiple interactions |
ISO |
zinc chloride results in increased stability of CYP1A1 mRNA; zinc chloride results in increased stability of CYP1A1 protein zinc chloride inhibits the reaction [1,10-phenanthroline inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 protein]] |
CTD |
PMID:19896525 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Dcp1b |
decapping mRNA 1B |
multiple interactions |
ISO |
[Clioquinol co-treated with zinc chloride] results in decreased expression of DCP1B mRNA |
CTD |
PMID:22415087 |
|
NCBI chr 4:152,358,267...152,395,747
Ensembl chr 4:152,358,241...152,397,145
|
|
G |
Ddx21 |
DExD-box helicase 21 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of DDX21 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr20:30,534,319...30,554,513
Ensembl chr20:30,534,319...30,554,543
|
|
G |
Dennd2b |
DENN domain containing 2B |
increases expression |
ISO |
zinc chloride results in increased expression of DENND2B mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 1:163,544,075...163,734,736
Ensembl chr 1:163,544,074...163,694,680
|
|
G |
Dhrs2 |
dehydrogenase/reductase 2 |
increases expression |
ISO |
zinc chloride results in increased expression of DHRS2 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr15:28,688,881...28,703,646
Ensembl chr15:28,688,940...28,703,644
|
|
G |
Dicer1 |
dicer 1 ribonuclease III |
multiple interactions |
ISO |
[Clioquinol co-treated with zinc chloride] results in decreased expression of DICER1 protein |
CTD |
PMID:22415087 |
|
NCBI chr 6:123,627,529...123,692,278
Ensembl chr 6:123,631,250...123,693,965
|
|
G |
Dll4 |
delta like canonical Notch ligand 4 |
multiple interactions |
ISO |
[zinc chloride results in increased abundance of Zinc] which results in decreased expression of DLL4 mRNA |
CTD |
PMID:31588059 |
|
NCBI chr 3:106,317,114...106,327,004
Ensembl chr 3:106,316,986...106,326,931
|
|
G |
Drd1 |
dopamine receptor D1 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [ecopipam binds to DRD1 protein]; zinc chloride inhibits the reaction [SCH 23390 binds to DRD1 protein] |
CTD |
PMID:9109525 |
|
NCBI chr17:10,540,440...10,544,971
Ensembl chr17:10,540,558...10,545,002
|
|
G |
Drd2 |
dopamine receptor D2 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [3-N-methylspiperone binds to DRD2 protein]; zinc chloride inhibits the reaction [Haloperidol binds to DRD2 protein] |
CTD |
PMID:9109525 |
|
NCBI chr 8:49,708,903...49,772,888
Ensembl chr 8:49,708,927...49,772,875
|
|
G |
Drosha |
drosha ribonuclease III |
multiple interactions |
ISO |
[Clioquinol co-treated with zinc chloride] affects the expression of DROSHA protein |
CTD |
PMID:22415087 |
|
NCBI chr 2:61,864,886...61,976,688
Ensembl chr 2:61,864,970...61,976,688
|
|
G |
Duox1 |
dual oxidase 1 |
multiple interactions |
ISO |
DUOX1 protein affects the reaction [zinc chloride results in increased secretion of CXCL8 protein] |
CTD |
PMID:27427241 |
|
NCBI chr 3:109,260,526...109,295,588
Ensembl chr 3:109,262,397...109,295,563
|
|
G |
Egfr |
epidermal growth factor receptor |
increases phosphorylation |
ISO |
zinc chloride results in increased phosphorylation of EGFR protein |
CTD |
PMID:21540303 |
|
NCBI chr14:91,176,931...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Egln1 |
egl-9 family hypoxia-inducible factor 1 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of EGLN1 mRNA]; zinc chloride inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased activity of EGLN1 protein] |
CTD |
PMID:16579968 PMID:22202117 |
|
NCBI chr19:52,867,914...52,907,169
Ensembl chr19:52,869,486...52,907,777
|
|
G |
Eif4e |
eukaryotic translation initiation factor 4E |
multiple interactions |
ISO |
[Clioquinol co-treated with zinc chloride] results in increased expression of EIF4E mRNA; [Clioquinol co-treated with zinc chloride] results in increased expression of EIF4E protein |
CTD |
PMID:22415087 |
|
NCBI chr 2:227,066,519...227,099,261
Ensembl chr 2:227,066,673...227,098,683
|
|
G |
Elk1 |
ETS transcription factor ELK1 |
multiple interactions increases activity |
EXP |
zinc chloride results in increased phosphorylation of and results in increased activity of ELK1 protein zinc chloride results in increased activity of ELK1 protein |
CTD |
PMID:16960431 PMID:20412391 |
|
NCBI chr X:1,138,826...1,155,713
Ensembl chr X:1,139,756...1,155,713
|
|
G |
Eno2 |
enolase 2 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ENO2 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
|
|
G |
Epo |
erythropoietin |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of EPO protein]; zinc chloride inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA] |
CTD |
PMID:11090055 |
|
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
|
|
G |
F2rl2 |
coagulation factor II (thrombin) receptor-like 2 |
decreases expression |
ISO |
zinc chloride results in decreased expression of F2RL2 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 2:26,972,054...26,977,098
Ensembl chr 2:26,972,054...26,977,098
|
|
G |
Fabp1 |
fatty acid binding protein 1 |
decreases expression |
ISO |
zinc chloride results in decreased expression of FABP1 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
|
|
G |
Fam162a |
family with sequence similarity 162, member A |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of FAM162A mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr11:64,680,937...64,711,239
Ensembl chr11:64,680,323...64,711,239
|
|
G |
Fasn |
fatty acid synthase |
decreases expression |
ISO |
zinc chloride results in decreased expression of FASN mRNA |
CTD |
PMID:21540303 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of FOS mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fosl1 |
FOS like 1, AP-1 transcription factor subunit |
increases expression |
ISO |
zinc chloride results in increased expression of FOSL1 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
|
|
G |
Foxa2 |
forkhead box A2 |
decreases expression |
ISO |
zinc chloride results in decreased expression of FOXA2 mRNA |
CTD |
PMID:21540303 |
|
NCBI chr 3:135,470,123...135,474,326
Ensembl chr 3:135,470,131...135,474,326
|
|
G |
Foxd1 |
forkhead box D1 |
increases expression |
ISO |
zinc chloride results in increased expression of FOXD1 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 2:29,702,558...29,704,978
Ensembl chr 2:29,702,558...29,704,978
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [Mercuric Chloride results in increased activity of G6PC1 protein] |
CTD |
PMID:22413763 |
|
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [Cadmium Chloride results in decreased activity of G6PD protein] |
CTD |
PMID:18972399 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression |
ISO |
zinc chloride results in increased expression of GADD45A mRNA |
CTD |
PMID:33645215 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gbe1 |
1,4-alpha-glucan branching enzyme 1 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of GBE1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr11:8,734,806...9,000,226
Ensembl chr11:8,734,820...9,000,210
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions increases expression |
ISO |
zinc chloride promotes the reaction [SLC39A2 protein results in increased expression of GCLC mRNA] zinc chloride results in increased expression of GCLC mRNA |
CTD |
PMID:18385089 PMID:33645215 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
multiple interactions |
ISO |
zinc chloride promotes the reaction [SLC39A2 protein results in increased expression of GCLM mRNA] |
CTD |
PMID:18385089 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [Vincristine results in increased expression of GJA1 protein] |
CTD |
PMID:34286406 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
increases expression |
ISO |
zinc chloride results in increased expression of GPX2 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Grik2 |
glutamate ionotropic receptor kainate type subunit 2 |
increases expression |
ISO |
zinc chloride results in increased expression of GRIK2 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr20:52,135,325...52,833,061
Ensembl chr20:52,133,851...52,838,375
|
|
G |
Grin2a |
glutamate ionotropic receptor NMDA type subunit 2A |
multiple interactions |
EXP |
AG 1879 inhibits the reaction [zinc chloride results in increased phosphorylation of GRIN2A protein]; zinc chloride results in increased expression of and results in increased phosphorylation of GRIN2A protein |
CTD |
PMID:12211081 |
|
NCBI chr10:5,630,684...6,043,341
Ensembl chr10:5,631,369...6,044,637
|
|
G |
Grin2b |
glutamate ionotropic receptor NMDA type subunit 2B |
multiple interactions |
EXP |
AG 1879 inhibits the reaction [zinc chloride results in increased phosphorylation of GRIN2B protein]; zinc chloride results in increased expression of and results in increased phosphorylation of GRIN2B protein |
CTD |
PMID:12211081 |
|
NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
|
|
G |
Grm5 |
glutamate metabotropic receptor 5 |
multiple interactions increases expression |
EXP |
Copper inhibits the reaction [zinc chloride results in increased expression of GRM5 protein] |
CTD |
PMID:25007851 |
|
NCBI chr 1:141,310,069...141,884,980
Ensembl chr 1:141,312,368...141,882,274
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
ISO EXP |
[Carmustine results in decreased activity of GSR protein] which results in increased susceptibility to zinc chloride zinc chloride inhibits the reaction [Cadmium Chloride results in increased activity of GSR protein]; zinc chloride inhibits the reaction [Copper results in decreased activity of GSR protein]; zinc chloride inhibits the reaction [Malathion results in decreased activity of GSR protein] |
CTD |
PMID:12632252 PMID:19429256 PMID:20600438 PMID:23726800 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
multiple interactions |
EXP |
[Cadmium Chloride co-treated with zinc chloride] results in increased expression of GSTP1 protein |
CTD |
PMID:15602745 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gys1 |
glycogen synthase 1 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of GYS1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 1:95,915,443...95,935,292
Ensembl chr 1:95,915,443...95,935,292
|
|
G |
H2ax |
H2A.X variant histone |
increases expression |
ISO |
zinc chloride results in increased expression of H2AX mRNA |
CTD |
PMID:18947441 |
|
NCBI chr 8:44,671,927...44,673,257
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Hcfc1r1 |
host cell factor C1 regulator 1 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of HCFC1R1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr10:12,705,139...12,706,852
Ensembl chr10:12,705,077...12,706,850
|
|
G |
Hdac1 |
histone deacetylase 1 |
multiple interactions |
ISO |
[zinc chloride results in increased abundance of Zinc] which results in decreased expression of HDAC1 mRNA |
CTD |
PMID:31588059 |
|
NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111
|
|
G |
Hells |
helicase, lymphoid specific |
increases expression |
ISO |
zinc chloride results in increased expression of HELLS mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 1:236,701,704...236,748,239
Ensembl chr 1:236,701,758...236,746,844
|
|
G |
Heph |
hephaestin |
decreases expression |
ISO |
zinc chloride results in decreased expression of HEPH mRNA |
CTD |
PMID:18947441 |
|
NCBI chr X:61,151,131...61,402,980
Ensembl chr X:61,296,345...61,402,980
|
|
G |
Hexb |
hexosaminidase subunit beta |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [2-phenylphenol results in increased secretion of HEXB protein]; zinc chloride inhibits the reaction [bitertanol results in increased secretion of HEXB protein]; zinc chloride inhibits the reaction [Butylated Hydroxyanisole results in increased secretion of HEXB protein]; zinc chloride inhibits the reaction [Butylated Hydroxytoluene results in increased secretion of HEXB protein]; zinc chloride inhibits the reaction [butylparaben results in increased secretion of HEXB protein]; zinc chloride inhibits the reaction [EPN oxon results in increased secretion of HEXB protein]; zinc chloride inhibits the reaction [Permethrin results in increased secretion of HEXB protein]; zinc chloride inhibits the reaction [prothiophos results in increased secretion of HEXB protein]; zinc chloride inhibits the reaction [pyridaben results in increased secretion of HEXB protein]; zinc chloride inhibits the reaction [salinomycin results in increased secretion of HEXB protein]; zinc chloride inhibits the reaction [terbufos results in increased secretion of HEXB protein] |
CTD |
PMID:15272608 |
|
NCBI chr 2:28,483,997...28,504,165
Ensembl chr 2:28,484,012...28,504,223
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions increases expression affects splicing |
ISO |
Cycloheximide inhibits the reaction [zinc chloride results in increased expression of HIF1A protein alternative form]; zinc chloride inhibits the reaction [cobaltous chloride inhibits the reaction [Doxorubicin promotes the reaction [HIPK2 protein binds to HIF1A promoter]]]; zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of HIF1A protein]; zinc chloride inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased stability of and results in increased expression of HIF1A protein]; zinc chloride inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]; zinc chloride inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein] [Doxorubicin co-treated with zinc chloride] results in decreased expression of HIF1A mRNA zinc chloride results in increased expression of HIF1A mRNA; zinc chloride results in increased expression of HIF1A mRNA alternative form; zinc chloride results in increased expression of HIF1A protein alternative form zinc chloride affects the splicing of HIF1A mRNA |
CTD |
PMID:11090055 PMID:11739637 PMID:16579968 PMID:19714248 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hilpda |
hypoxia inducible lipid droplet-associated |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of HILPDA mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 4:57,871,076...57,875,206
Ensembl chr 4:57,871,110...57,874,557
|
|
G |
Hipk2 |
homeodomain interacting protein kinase 2 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride inhibits the reaction [Doxorubicin promotes the reaction [HIPK2 protein binds to HIF1A promoter]]]; zinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of HIPK2 protein]; zinc chloride inhibits the reaction [Oxygen deficiency results in decreased expression of HIPK2 protein] [Doxorubicin co-treated with zinc chloride] results in increased expression of HIPK2 mRNA |
CTD |
PMID:19714248 |
|
NCBI chr 4:67,439,327...67,619,223
Ensembl chr 4:67,440,501...67,619,223
|
|
G |
Hk2 |
hexokinase 2 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of HK2 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:115,234,509...115,283,530
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression multiple interactions |
ISO |
zinc chloride results in increased expression of HMOX1 mRNA; zinc chloride results in increased expression of HMOX1 protein HMOX1 enhancer affects the reaction [zinc chloride results in increased expression of HMOX1 mRNA] zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of HMOX1 mRNA] |
CTD |
PMID:7538129 PMID:16870260 PMID:22202117 PMID:27427241 PMID:33645215 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
increases expression |
ISO |
zinc chloride results in increased expression of HSPA1B mRNA |
CTD |
PMID:12085988 |
|
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
increases expression |
ISO |
zinc chloride results in increased expression of HSPA1A mRNA |
CTD |
PMID:12085988 PMID:16870260 |
|
NCBI chr20:3,870,765...3,873,221
|
|
G |
Hspa6l-ps1 |
heat shock protein family A (Hsp70) member 6 like, pseudogene 1 |
increases expression |
ISO |
zinc chloride results in increased expression of HSPA6 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr13:83,271,340...83,275,267
|
|
G |
Hspd1 |
heat shock protein family D (Hsp60) member 1 |
increases expression |
EXP |
zinc chloride results in increased expression of HSPD1 protein |
CTD |
PMID:19429256 |
|
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
[zinc chloride results in increased abundance of Zinc] which results in decreased expression of IFNG mRNA; zinc chloride inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]] |
CTD |
PMID:8975779 PMID:31588059 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
decreases expression |
ISO |
zinc chloride results in decreased expression of IKBKB mRNA |
CTD |
PMID:21540303 |
|
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
|
|
G |
Il10 |
interleukin 10 |
increases expression |
ISO |
zinc chloride results in increased expression of IL10 mRNA |
CTD |
PMID:24284788 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il10rb |
interleukin 10 receptor subunit beta |
decreases expression |
ISO |
zinc chloride results in decreased expression of IL10RB mRNA |
CTD |
PMID:19428942 |
|
NCBI chr11:30,646,494...30,668,081
Ensembl chr11:30,652,096...30,668,074
|
|
G |
Il12b |
interleukin 12B |
decreases expression |
ISO |
zinc chloride results in decreased expression of IL12B mRNA |
CTD |
PMID:24284788 |
|
NCBI chr10:28,888,832...28,903,796
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il18r1 |
interleukin 18 receptor 1 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of IL18R1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 9:42,727,416...42,760,971
Ensembl chr 9:42,727,869...42,760,715
|
|
G |
Il1a |
interleukin 1 alpha |
increases expression multiple interactions |
ISO |
zinc chloride results in increased expression of IL1A protein N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [zinc chloride results in increased expression of IL1A protein]; NCF1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of IL1A protein]; PARP1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of IL1A protein] |
CTD |
PMID:18509044 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases expression |
ISO |
N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [zinc chloride results in increased expression of IL1B protein]; NCF1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of IL1B protein]; PARP1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of IL1B protein]; zinc chloride inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased secretion of IL1B protein]] zinc chloride results in increased expression of IL1B mRNA zinc chloride inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] |
CTD |
PMID:9138684 PMID:18509044 PMID:19130485 PMID:27427241 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1rl1 |
interleukin 1 receptor-like 1 |
increases expression |
ISO |
zinc chloride results in increased expression of IL1RL1 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
increases expression |
ISO |
zinc chloride results in increased expression of IL1RN mRNA |
CTD |
PMID:19428942 |
|
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Il3 |
interleukin 3 |
multiple interactions increases expression |
ISO |
N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [zinc chloride results in increased expression of IL3 protein]; NCF1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of IL3 protein]; PARP1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of IL3 protein] |
CTD |
PMID:18509044 |
|
NCBI chr10:38,405,716...38,408,066
Ensembl chr10:38,405,716...38,408,066
|
|
G |
Il36rn |
interleukin 36 receptor antagonist |
decreases expression |
ISO |
zinc chloride results in decreased expression of IL36RN mRNA |
CTD |
PMID:19428942 |
|
NCBI chr 3:7,044,419...7,051,016
Ensembl chr 3:7,044,406...7,051,016
|
|
G |
Il6 |
interleukin 6 |
increases secretion multiple interactions increases expression |
ISO |
zinc chloride results in increased secretion of IL6 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [zinc chloride results in increased secretion of IL6 protein]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [zinc chloride results in increased secretion of IL6 protein]; Acetylcysteine inhibits the reaction [zinc chloride results in increased secretion of IL6 protein]; RELA protein affects the reaction [zinc chloride results in increased secretion of IL6 protein]; Thiourea inhibits the reaction [zinc chloride results in increased secretion of IL6 protein] zinc chloride results in increased expression of IL6 mRNA |
CTD |
PMID:21842098 PMID:27427241 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Insig2 |
insulin induced gene 2 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of INSIG2 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr13:32,472,390...32,500,139
Ensembl chr13:32,473,742...32,494,923
|
|
G |
Insr |
insulin receptor |
increases phosphorylation |
ISO |
zinc chloride results in increased phosphorylation of INSR protein |
CTD |
PMID:11340092 |
|
NCBI chr12:1,193,193...1,330,976
Ensembl chr12:1,197,100...1,330,883
|
|
G |
Ireb2 |
iron responsive element binding protein 2 |
increases expression |
ISO |
zinc chloride results in increased expression of IREB2 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr 8:55,228,080...55,311,613
Ensembl chr 8:55,228,085...55,311,611
|
|
G |
Itgb6 |
integrin subunit beta 6 |
increases expression |
ISO |
zinc chloride results in increased expression of ITGB6 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 3:45,046,295...45,170,532
Ensembl chr 3:45,048,044...45,121,671
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
increases expression multiple interactions |
ISO |
zinc chloride results in increased expression of JUN mRNA [[cupric chloride results in increased abundance of Copper] co-treated with [zinc chloride results in increased abundance of Zinc]] results in increased phosphorylation of JUN protein; Acetylcysteine inhibits the reaction [zinc chloride results in increased expression of JUN mRNA]; pyrazolanthrone inhibits the reaction [[[cupric chloride results in increased abundance of Copper] co-treated with [zinc chloride results in increased abundance of Zinc]] results in increased phosphorylation of JUN protein] |
CTD |
PMID:11306679 PMID:19000923 PMID:21540303 PMID:30768131 PMID:33645215 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
zinc chloride results in increased expression of JUNB mRNA |
CTD |
PMID:19000923 |
|
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
|
|
G |
Kat5 |
lysine acetyltransferase 5 |
multiple interactions |
ISO |
zinc chloride affects the reaction [4-aminophenylarsenoxide binds to KAT5 protein] |
CTD |
PMID:28837777 |
|
NCBI chr 1:202,895,751...202,903,178
Ensembl chr 1:202,895,751...202,903,458
|
|
G |
Kdm3a |
lysine demethylase 3A |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of KDM3A mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 4:103,630,907...103,675,073
Ensembl chr 4:103,630,908...103,675,073
|
|
G |
Kdm4b |
lysine demethylase 4B |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of KDM4B mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 9:1,158,737...1,237,228
Ensembl chr 9:1,158,752...1,236,543
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
affects folding multiple interactions |
ISO |
zinc chloride affects the folding of KEAP1 protein zinc chloride promotes the reaction [KEAP1 protein binds to KEAP1 protein] |
CTD |
PMID:30261176 |
|
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Kif5a |
kinesin family member 5A |
multiple interactions decreases activity |
ISO |
Adenosine Triphosphate inhibits the reaction [zinc chloride results in decreased activity of KIF5A protein]; Magnesium Chloride affects the reaction [zinc chloride results in decreased activity of KIF5A protein] |
CTD |
PMID:28122263 |
|
NCBI chr 7:63,051,894...63,089,024
Ensembl chr 7:63,049,424...63,092,858
|
|
G |
Lep |
leptin |
increases expression |
ISO |
zinc chloride results in increased expression of LEP mRNA |
CTD |
PMID:21540303 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Limch1 |
LIM and calponin homology domains 1 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of LIMCH1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr14:41,112,579...41,425,185
Ensembl chr14:41,114,803...41,425,191
|
|
G |
Lta |
lymphotoxin alpha |
decreases expression increases expression |
ISO |
zinc chloride results in decreased expression of LTA mRNA zinc chloride results in increased expression of LTA mRNA |
CTD |
PMID:19428942 PMID:21540303 |
|
NCBI chr20:3,618,853...3,621,324
Ensembl chr20:3,618,853...3,620,859
|
|
G |
Ltb4r |
leukotriene B4 receptor |
decreases expression |
ISO |
zinc chloride results in decreased expression of LTB4R mRNA |
CTD |
PMID:19428942 |
|
NCBI chr15:29,263,126...29,265,716
|
|
G |
Maff |
MAF bZIP transcription factor F |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of MAFF mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 7:110,912,499...110,923,851
Ensembl chr 7:110,912,499...110,923,851
|
|
G |
Mafg |
MAF bZIP transcription factor G |
increases expression |
ISO |
zinc chloride results in increased expression of MAFG mRNA |
CTD |
PMID:11162468 |
|
NCBI chr10:105,903,307...105,911,845
Ensembl chr10:105,903,237...105,912,026
|
|
G |
Maml1 |
mastermind-like transcriptional coactivator 1 |
multiple interactions |
ISO |
[zinc chloride results in increased abundance of Zinc] which results in increased expression of MAML1 mRNA |
CTD |
PMID:31588059 |
|
NCBI chr10:34,588,639...34,624,298
Ensembl chr10:34,588,646...34,623,338
|
|
G |
Map2k4 |
mitogen activated protein kinase kinase 4 |
increases activity |
ISO |
zinc chloride results in increased activity of MAP2K4 protein |
CTD |
PMID:11306679 |
|
NCBI chr10:50,343,227...50,447,956
Ensembl chr10:50,344,915...50,447,993
|
|
G |
Map3k1 |
mitogen-activated protein kinase kinase kinase 1 |
multiple interactions increases activity |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [zinc chloride results in increased activity of MAP3K1 protein]; PIK3CG protein affects the reaction [zinc chloride results in increased activity of MAP3K1 protein] |
CTD |
PMID:11306679 |
|
NCBI chr 2:43,348,572...43,414,706
Ensembl chr 2:43,350,098...43,414,463
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases activity increases phosphorylation |
EXP ISO |
N,N'-diphenyl-4-phenylenediamine inhibits the reaction [zinc chloride results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [zinc chloride results in increased phosphorylation of MAPK1 protein]; zinc chloride results in increased phosphorylation of and results in increased activity of MAPK1 protein zinc chloride results in increased activity of MAPK1 protein |
CTD |
PMID:11306679 PMID:11551972 PMID:16960431 PMID:20412391 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases phosphorylation |
EXP |
1,3-dimethylthiourea inhibits the reaction [zinc chloride results in increased phosphorylation of MAPK3 protein]; AG 1879 inhibits the reaction [zinc chloride results in increased phosphorylation of MAPK3 protein]; Go 6976 inhibits the reaction [zinc chloride results in increased phosphorylation of MAPK3 protein]; manumycin inhibits the reaction [zinc chloride results in increased phosphorylation of MAPK3 protein]; N,N'-diphenyl-4-phenylenediamine inhibits the reaction [zinc chloride results in increased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [zinc chloride results in increased phosphorylation of MAPK3 protein]; Vanadates promotes the reaction [zinc chloride results in increased phosphorylation of MAPK3 protein]; zinc chloride results in increased phosphorylation of and results in increased activity of MAPK3 protein |
CTD |
PMID:16960431 PMID:20412391 PMID:21575692 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [zinc chloride results in increased activity of MAPK8 protein]; [[cupric chloride results in increased abundance of Copper] co-treated with [zinc chloride results in increased abundance of Zinc]] results in increased phosphorylation of MAPK8 protein; Acetylcysteine inhibits the reaction [zinc chloride results in increased activity of MAPK8 protein]; PIK3CG protein affects the reaction [zinc chloride results in increased activity of MAPK8 protein]; pyrazolanthrone inhibits the reaction [[[cupric chloride results in increased abundance of Copper] co-treated with [zinc chloride results in increased abundance of Zinc]] results in increased phosphorylation of MAPK8 protein]; RAC1 protein affects the reaction [zinc chloride results in increased activity of MAPK8 protein]; zinc chloride inhibits the reaction [Acetaminophen results in increased phosphorylation of MAPK8 protein]; zinc chloride results in increased phosphorylation of and results in increased activity of MAPK8 protein |
CTD |
PMID:11306679 PMID:20423716 PMID:30768131 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [Acetaminophen results in increased phosphorylation of MAPK9 protein] |
CTD |
PMID:20423716 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Mcm3 |
minichromosome maintenance complex component 3 |
increases expression |
ISO |
zinc chloride results in increased expression of MCM3 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:23,219,169...23,237,314
|
|
G |
Mif |
macrophage migration inhibitory factor |
decreases expression |
ISO |
zinc chloride results in decreased expression of MIF mRNA |
CTD |
PMID:18947441 |
|
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
|
|
G |
Mir130a |
microRNA 130a |
multiple interactions |
ISO |
[Clioquinol co-treated with zinc chloride] results in decreased expression of MIR130A mRNA |
CTD |
PMID:22415087 |
|
NCBI chr 3:69,822,542...69,822,629
Ensembl chr 3:69,822,542...69,822,629
|
|
G |
Mir223 |
microRNA 223 |
multiple interactions |
ISO |
[Clioquinol co-treated with zinc chloride] results in decreased expression of MIR223 mRNA |
CTD |
PMID:22415087 |
|
NCBI chr X:61,141,887...61,141,996
Ensembl chr X:61,141,887...61,141,996
|
|
G |
Mir29a |
microRNA 29a |
multiple interactions |
ISO |
[Clioquinol co-treated with zinc chloride] results in decreased expression of MIR29A mRNA |
CTD |
PMID:22415087 |
|
NCBI chr 4:59,650,608...59,650,695
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [Ellagic Acid results in decreased activity of and results in decreased secretion of MMP2 protein] |
CTD |
PMID:21573219 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
decreases expression |
ISO |
zinc chloride results in decreased expression of MMP7 mRNA |
CTD |
PMID:21540303 |
|
NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:4,848,186...4,855,902
|
|
G |
Mt1 |
metallothionein 1 |
multiple interactions increases expression |
EXP |
zinc chloride promotes the reaction [Glucose results in increased expression of MT1A mRNA] zinc chloride results in increased expression of MT1A mRNA; zinc chloride results in increased expression of MT1A protein |
CTD |
PMID:8928928 PMID:17637929 PMID:23056475 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049
|
|
G |
Mt1-ps3 |
metallothionein 1, pseudogene 3 |
increases expression |
ISO |
zinc chloride results in increased expression of MT1E mRNA |
CTD |
PMID:16870260 |
|
NCBI chr17:74,786,652...74,787,040
Ensembl chr17:74,786,654...74,787,135
|
|
G |
Mt2A |
metallothionein 2A |
multiple interactions affects binding affects response to substance increases expression |
ISO EXP |
[zinc chloride co-treated with pyrithione zinc] results in increased expression of MT2A mRNA; Dactinomycin inhibits the reaction [zinc chloride results in increased expression of MT2A mRNA]; epigallocatechin gallate inhibits the reaction [zinc chloride results in increased expression of MT2A mRNA]; Grape Seed Proanthocyanidins inhibits the reaction [zinc chloride results in increased expression of MT2A mRNA]; zinc chloride inhibits the reaction [Lipopolysaccharides results in increased expression of MT2A mRNA] zinc chloride promotes the reaction [Cadmium Chloride results in increased expression of MT2 mRNA] zinc chloride binds to MT2 protein MT2 affects the susceptibility to zinc chloride zinc chloride results in increased expression of MT2 mRNA; zinc chloride results in increased expression of MT2 protein zinc chloride results in increased expression of MT2A mRNA; zinc chloride results in increased expression of MT2A protein zinc chloride promotes the reaction [Glucose results in increased expression of MT2A mRNA] |
CTD |
PMID:9138684 PMID:15288509 PMID:16842966 PMID:16870260 PMID:16987576 PMID:17234632 PMID:17637929 PMID:18947441 PMID:19835899 PMID:20471814 PMID:20801194 PMID:23056475 PMID:33645215 More...
|
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mt3 |
metallothionein 3 |
increases expression |
ISO |
zinc chloride results in increased expression of MT3 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr19:10,848,754...10,850,158
Ensembl chr19:10,848,755...10,850,158
|
|
G |
Mta2 |
metastasis associated 1 family, member 2 |
decreases expression |
ISO |
zinc chloride results in decreased expression of MTA2 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 1:205,838,181...205,846,903
Ensembl chr 1:205,837,964...205,846,946
|
|
G |
Mtf1 |
metal-regulatory transcription factor 1 |
multiple interactions affects localization decreases expression |
ISO |
zinc chloride results in increased phosphorylation of and results in increased activity of MTF1 protein zinc chloride affects the localization of MTF1 protein zinc chloride results in decreased expression of MTF1 mRNA |
CTD |
PMID:11551972 PMID:16423564 PMID:18947441 |
|
NCBI chr 5:137,062,319...137,107,136
Ensembl chr 5:137,062,376...137,107,136
|
|
G |
Mtf2 |
metal response element binding transcription factor 2 |
decreases expression |
ISO |
zinc chloride results in decreased expression of MTF2 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr14:1,639,256...1,683,513
Ensembl chr14:1,640,746...1,683,524
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
multiple interactions increases response to substance |
ISO |
NCF1 gene mutant form inhibits the reaction [zinc chloride results in increased activity of PARP1 protein]; NCF1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of ADGRE1 protein]; NCF1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of CSF2 protein]; NCF1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of IL1A protein]; NCF1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of IL1B protein]; NCF1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of IL3 protein] NCF1 results in increased susceptibility to zinc chloride |
CTD |
PMID:18509044 |
|
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
|
|
G |
Ndrg1 |
N-myc downstream regulated 1 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of NDRG1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
|
|
G |
Ndufaf5 |
NADH:ubiquinone oxidoreductase complex assembly factor 5 |
decreases expression |
ISO |
zinc chloride results in decreased expression of NDUFAF5 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 3:127,507,931...127,537,477
Ensembl chr 3:127,507,941...127,537,477
|
|
G |
Nf2 |
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor |
decreases expression |
ISO |
zinc chloride results in decreased expression of NF2 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr14:79,627,399...79,710,709
Ensembl chr14:79,627,399...79,710,667
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
affects response to substance multiple interactions |
ISO |
[NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to zinc chloride zinc chloride promotes the reaction [SLC39A2 protein results in increased activity of NFE2L2 protein] |
CTD |
PMID:18385089 PMID:19303893 |
|
NCBI chr 3:60,594,239...60,621,785
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
increases activity |
ISO |
zinc chloride results in increased activity of NFKB1 protein |
CTD |
PMID:21842098 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nip7 |
nucleolar pre-rRNA processing protein NIP7 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of NIP7 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr19:34,962,557...34,964,700
Ensembl chr19:34,962,557...34,964,711
|
|
G |
Nmnat1 |
nicotinamide nucleotide adenylyltransferase 1 |
multiple interactions |
ISO |
[zinc chloride results in increased abundance of Zinc] which results in increased expression of NMNAT1 mRNA |
CTD |
PMID:31588059 |
|
NCBI chr 5:159,910,242...159,928,201
Ensembl chr 5:159,910,242...159,928,180
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]] |
CTD |
PMID:8975779 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nox4 |
NADPH oxidase 4 |
increases expression |
ISO |
zinc chloride results in increased expression of NOX4 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
|
|
G |
Ntn3 |
netrin 3 |
multiple interactions |
ISO |
[zinc chloride results in increased abundance of Zinc] which results in increased expression of NTN3 mRNA |
CTD |
PMID:31588059 |
|
NCBI chr10:13,236,905...13,240,001
Ensembl chr10:13,236,905...13,240,001
|
|
G |
Or2ag2 |
olfactory receptor family 2 subfamily AG member 2 |
multiple interactions |
ISO |
[zinc chloride results in increased abundance of Zinc] which results in increased expression of OR2AG2 mRNA |
CTD |
PMID:31588059 |
|
NCBI chr 1:160,695,621...160,696,571
Ensembl chr 1:160,695,621...160,696,571
|
|
G |
Or4c12 |
olfactory receptor family 4 subfamily C member 12 |
multiple interactions |
ISO |
[zinc chloride results in increased abundance of Zinc] which results in decreased expression of OR4C12 mRNA |
CTD |
PMID:31588059 |
|
NCBI chr 3:75,947,266...75,948,186
Ensembl chr 3:75,946,552...75,952,943
|
|
G |
Orm1 |
orosomucoid 1 |
increases expression |
ISO |
zinc chloride results in increased expression of ORM1 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 5:76,766,637...76,776,149
Ensembl chr 5:76,772,941...76,776,154
|
|
G |
P2rx2 |
purinergic receptor P2X 2 |
multiple interactions |
EXP |
zinc chloride promotes the reaction [Adenosine Triphosphate results in increased activity of P2RX2 protein] |
CTD |
PMID:16190872 |
|
NCBI chr12:46,338,979...46,342,891
Ensembl chr12:46,339,549...46,342,891
|
|
G |
P4ha1 |
prolyl 4-hydroxylase subunit alpha 1 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of P4HA1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr20:27,302,046...27,352,098
Ensembl chr20:27,302,141...27,352,786
|
|
G |
P4ha2 |
prolyl 4-hydroxylase subunit alpha 2 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of P4HA2 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr10:38,243,047...38,271,989
Ensembl chr10:38,243,139...38,287,314
|
|
G |
Paip1 |
poly(A) binding protein interacting protein 1 |
decreases expression |
ISO |
zinc chloride results in decreased expression of PAIP1 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr 2:51,523,142...51,550,241
Ensembl chr 2:51,522,921...51,550,241
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions increases expression increases activity increases response to substance |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein]]; zinc chloride inhibits the reaction [sodium arsenite results in decreased activity of PARP1 protein]; zinc chloride promotes the reaction [Hydrogen Peroxide results in increased activity of PARP1 protein] zinc chloride results in increased expression of PARP1 protein zinc chloride results in increased activity of PARP1 protein PARP1 results in increased susceptibility to zinc chloride 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [zinc chloride results in increased expression of PARP1 protein]; acetovanillone inhibits the reaction [zinc chloride results in increased activity of PARP1 protein]; Cibacron Blue F 3GA inhibits the reaction [zinc chloride results in increased expression of PARP1 protein]; coomassie Brilliant Blue inhibits the reaction [zinc chloride results in increased expression of PARP1 protein]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [zinc chloride results in increased expression of PARP1 protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [zinc chloride results in increased activity of PARP1 protein]; NCF1 gene mutant form inhibits the reaction [zinc chloride results in increased activity of PARP1 protein]; PARP1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of ADGRE1 protein]; PARP1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of CSF2 protein]; PARP1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of IL1A protein]; PARP1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of IL1B protein]; PARP1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of IL3 protein]; periodate-oxidized adenosine 5'-triphosphate inhibits the reaction [zinc chloride results in increased expression of PARP1 protein]; pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid inhibits the reaction [zinc chloride results in increased expression of PARP1 protein] |
CTD |
PMID:18509044 PMID:19056730 PMID:19714248 PMID:22253048 PMID:33645215 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pcbd1 |
pterin-4 alpha-carbinolamine dehydratase 1 |
increases expression |
ISO |
zinc chloride results in increased expression of PCBD1 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr20:29,037,545...29,044,322
Ensembl chr20:28,953,864...29,044,292 Ensembl chr20:28,953,864...29,044,292
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
EXP |
[Cadmium Chloride co-treated with zinc chloride] results in increased expression of PCNA protein |
CTD |
PMID:15602745 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pdap1 |
PDGFA associated protein 1 |
multiple interactions |
ISO |
zinc chloride promotes the reaction [Cadmium Chloride results in increased expression of PDAP1 mRNA] |
CTD |
PMID:16842966 |
|
NCBI chr12:9,470,652...9,480,880
Ensembl chr12:9,470,574...9,535,374
|
|
G |
Pdk1 |
pyruvate dehydrogenase kinase 1 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of PDK1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 3:56,705,824...56,733,040
Ensembl chr 3:56,705,871...56,733,038
|
|
G |
Peg3 |
paternally expressed 3 |
decreases expression |
ISO |
zinc chloride results in decreased expression of PEG3 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 1:67,097,874...67,124,692
Ensembl chr 1:67,097,904...67,124,671
|
|
G |
Pfkfb3 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of PFKFB3 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr17:66,983,629...67,064,702
Ensembl chr17:66,983,686...67,063,125
|
|
G |
Pfkfb4 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of PFKFB4 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 8:109,643,558...109,687,006
Ensembl chr 8:109,643,937...109,685,634
|
|
G |
Pgf |
placental growth factor |
increases expression |
ISO |
zinc chloride results in increased expression of PGF mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 6:104,816,102...104,826,685
Ensembl chr 6:104,816,104...104,826,685
|
|
G |
Pgk1 |
phosphoglycerate kinase 1 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of PGK1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr X:71,271,454...71,287,429
Ensembl chr X:71,271,440...71,287,418
|
|
G |
Pgm1 |
phosphoglucomutase 1 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of PGM1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 5:114,595,298...114,654,728
Ensembl chr 5:114,595,293...114,654,728
|
|
G |
Phex |
phosphate regulating endopeptidase X-linked |
increases expression |
ISO |
zinc chloride results in increased expression of PHEX mRNA |
CTD |
PMID:19000923 |
|
NCBI chr X:37,607,553...37,856,183
Ensembl chr X:37,610,760...37,854,469
|
|
G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
multiple interactions |
ISO |
PIK3CG protein affects the reaction [zinc chloride results in increased activity of MAP3K1 protein]; PIK3CG protein affects the reaction [zinc chloride results in increased activity of MAPK8 protein] |
CTD |
PMID:11306679 |
|
NCBI chr 6:48,766,778...48,802,098
Ensembl chr 6:48,766,864...48,802,043
|
|
G |
Pik3r4 |
phosphoinositide-3-kinase, regulatory subunit 4 |
increases expression |
ISO |
zinc chloride results in increased expression of PIK3R4 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 8:106,267,908...106,316,585
Ensembl chr 8:106,267,954...106,316,584
|
|
G |
Pik3r5 |
phosphoinositide-3-kinase, regulatory subunit 5 |
increases expression |
ISO |
zinc chloride results in increased expression of PIK3R5 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr10:53,132,585...53,200,663
Ensembl chr10:53,132,603...53,199,374
|
|
G |
Pmp22 |
peripheral myelin protein 22 |
increases expression |
ISO |
zinc chloride results in increased expression of PMP22 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr10:47,795,709...47,825,715
Ensembl chr10:47,795,709...47,825,714
|
|
G |
Prkca |
protein kinase C, alpha |
multiple interactions affects localization |
EXP |
1,3-dimethylthiourea inhibits the reaction [zinc chloride affects the localization of and results in increased activity of PRKCA protein]; 1,3-dimethylthiourea inhibits the reaction [zinc chloride affects the localization of PRKCA protein]; Glucose promotes the reaction [zinc chloride affects the localization of and results in increased activity of PRKCA protein]; Vanadates promotes the reaction [zinc chloride affects the localization of PRKCA protein]; zinc chloride affects the localization of and results in increased activity of PRKCA protein |
CTD |
PMID:20800666 PMID:21575692 |
|
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
|
|
G |
Pth1r |
parathyroid hormone 1 receptor |
multiple interactions |
ISO |
[zinc chloride deficiency co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in decreased expression of PTH1R mRNA |
CTD |
PMID:19913120 |
|
NCBI chr 8:110,693,910...110,725,458
Ensembl chr 8:110,697,485...110,719,729
|
|
G |
Rab20 |
RAB20, member RAS oncogene family |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of RAB20 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr16:78,019,337...78,043,529
Ensembl chr16:78,019,337...78,043,529
|
|
G |
Rac1 |
Rac family small GTPase 1 |
multiple interactions |
ISO |
RAC1 protein affects the reaction [zinc chloride results in increased activity of MAPK8 protein] |
CTD |
PMID:11306679 |
|
NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
|
|
G |
Rad21 |
RAD21 cohesin complex component |
increases expression |
ISO |
zinc chloride results in increased expression of RAD21 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 7:83,287,867...83,314,810
Ensembl chr 7:83,287,870...83,314,817
|
|
G |
Rad51ap1 |
RAD51 associated protein 1 |
increases expression |
ISO |
zinc chloride results in increased expression of RAD51AP1 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 4:159,759,454...159,772,524
Ensembl chr 4:159,759,459...159,772,524
|
|
G |
Raf1 |
Raf-1 proto-oncogene, serine/threonine kinase |
multiple interactions increases phosphorylation |
EXP |
1,3-dimethylthiourea inhibits the reaction [zinc chloride results in increased phosphorylation of RAF1 protein]; AG 1879 inhibits the reaction [zinc chloride results in increased phosphorylation of RAF1 protein]; Go 6976 inhibits the reaction [zinc chloride results in increased phosphorylation of RAF1 protein]; manumycin inhibits the reaction [zinc chloride results in increased phosphorylation of RAF1 protein] |
CTD |
PMID:21575692 |
|
NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
|
|
G |
Rangap1 |
RAN GTPase activating protein 1 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of RANGAP1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 7:113,224,695...113,250,441
Ensembl chr 7:113,224,703...113,250,438
|
|
G |
Rbpj |
recombination signal binding protein for immunoglobulin kappa J region |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of RBPJ mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr14:57,338,493...57,523,330
Ensembl chr14:57,338,507...57,523,353
|
|
G |
Reck |
reversion-inducing-cysteine-rich protein with kazal motifs |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [Ellagic Acid results in increased expression of RECK mRNA]; zinc chloride inhibits the reaction [Ellagic Acid results in increased expression of RECK protein] |
CTD |
PMID:21573219 |
|
NCBI chr 5:58,102,915...58,169,513
Ensembl chr 5:58,102,981...58,169,502
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
increases phosphorylation multiple interactions |
ISO |
zinc chloride results in increased phosphorylation of RELA protein RELA protein affects the reaction [zinc chloride results in increased secretion of CXCL8 protein]; RELA protein affects the reaction [zinc chloride results in increased secretion of IL6 protein] |
CTD |
PMID:27427241 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rif1 |
replication timing regulatory factor 1 |
increases expression |
ISO |
zinc chloride results in increased expression of RIF1 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 3:36,554,689...36,607,961
Ensembl chr 3:36,554,697...36,603,617
|
|
G |
Riok3 |
RIO kinase 3 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of RIOK3 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr18:3,327,776...3,353,350
Ensembl chr18:3,327,776...3,353,343
|
|
G |
Rora |
RAR-related orphan receptor A |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of RORA mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 8:69,301,635...70,034,741
Ensembl chr 8:69,301,733...70,025,931
|
|
G |
Rpl11 |
ribosomal protein L11 |
decreases expression |
ISO |
zinc chloride results in decreased expression of RPL11 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr 5:148,274,060...148,277,708
Ensembl chr 5:148,274,069...148,277,599
|
|
G |
Rrp15 |
ribosomal RNA processing 15 homolog |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of RRP15 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr13:98,276,276...98,299,357
Ensembl chr13:98,276,134...98,299,370
|
|
G |
Rrs1 |
ribosome biogenesis regulator 1 homolog |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of RRS1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 5:9,733,486...9,735,119
Ensembl chr 5:9,733,091...9,735,140
|
|
G |
Runx2 |
RUNX family transcription factor 2 |
multiple interactions |
ISO |
[zinc chloride co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in increased expression of RUNX2 protein; [zinc chloride deficiency co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in decreased expression of RUNX2 mRNA; [zinc chloride deficiency co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in decreased expression of RUNX2 protein |
CTD |
PMID:19913120 |
|
NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
|
|
G |
Ruvbl1 |
RuvB-like AAA ATPase 1 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of RUVBL1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 4:120,932,486...120,967,400
Ensembl chr 4:120,932,417...121,029,384
|
|
G |
Sall1 |
spalt-like transcription factor 1 |
multiple interactions |
ISO |
[zinc chloride results in increased abundance of Zinc] which results in increased expression of SALL1 mRNA |
CTD |
PMID:31588059 |
|
NCBI chr19:18,005,782...18,022,705
Ensembl chr19:18,007,503...18,022,705
|
|
G |
Sap30 |
Sin3A associated protein 30 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of SAP30 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr16:32,747,739...32,753,114
Ensembl chr16:32,747,734...32,753,112
|
|
G |
Sbno1 |
strawberry notch homolog 1 |
increases expression |
ISO |
zinc chloride results in increased expression of SBNO1 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr12:32,175,176...32,234,200
Ensembl chr12:32,185,485...32,230,158
|
|
G |
Scara3 |
scavenger receptor class A, member 3 |
decreases expression |
ISO |
zinc chloride results in decreased expression of SCARA3 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr15:40,139,873...40,172,866
Ensembl chr15:40,140,161...40,172,894
|
|
G |
Scarb1 |
scavenger receptor class B, member 1 |
increases expression |
ISO |
zinc chloride results in increased expression of SCARB1 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
|
|
G |
Scd |
stearoyl-CoA desaturase |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of SCD mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Selplg |
selectin P ligand |
increases expression |
ISO |
zinc chloride results in increased expression of SELPLG mRNA |
CTD |
PMID:21540303 |
|
NCBI chr12:42,796,690...42,809,908
Ensembl chr12:42,796,580...42,812,585
|
|
G |
Sertad2 |
SERTA domain containing 2 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of SERTAD2 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr14:94,733,637...94,838,200
Ensembl chr14:94,733,579...94,838,313
|
|
G |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
multiple interactions increases expression |
EXP |
[COMMD1 protein co-treated with zinc chloride co-treated with cupric chloride] results in increased expression of SHANK2 protein; Copper inhibits the reaction [zinc chloride results in increased expression of SHANK2 protein] |
CTD |
PMID:25007851 |
|
NCBI chr 1:199,146,210...199,590,962
Ensembl chr 1:199,169,429...199,589,394
|
|
G |
Shank3 |
SH3 and multiple ankyrin repeat domains 3 |
multiple interactions increases expression |
EXP |
[COMMD1 protein co-treated with zinc chloride co-treated with cupric chloride] results in increased expression of SHANK3 protein; Copper inhibits the reaction [zinc chloride results in increased expression of SHANK3 protein] |
CTD |
PMID:25007851 |
|
NCBI chr 7:120,568,707...120,630,796
Ensembl chr 7:120,570,402...120,630,374
|
|
G |
Slc11a2 |
solute carrier family 11 member 2 |
increases transport |
ISO |
SLC11A2 protein results in increased transport of zinc chloride |
CTD |
PMID:22736759 |
|
NCBI chr 7:131,503,076...131,540,246
Ensembl chr 7:131,503,081...131,540,145
|
|
G |
Slc16a3 |
solute carrier family 16 member 3 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of SLC16A3 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr10:106,212,679...106,222,564
Ensembl chr10:106,212,778...106,222,562
|
|
G |
Slc1a2 |
solute carrier family 1 member 2 |
multiple interactions |
ISO |
[Kainic Acid co-treated with zinc chloride] results in decreased expression of SLC1A2 protein |
CTD |
PMID:19061913 |
|
NCBI chr 3:89,005,129...89,126,498
Ensembl chr 3:89,005,129...89,126,498
|
|
G |
Slc1a5 |
solute carrier family 1 member 5 |
decreases expression |
ISO |
zinc chloride results in decreased expression of SLC1A5 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr 1:77,456,849...77,470,952
Ensembl chr 1:77,456,694...77,470,952
|
|
G |
Slc25a15 |
solute carrier family 25 member 15 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of SLC25A15 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr16:69,631,581...69,654,869
Ensembl chr16:69,634,414...69,653,010
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
multiple interactions increases expression |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of SLC2A1 mRNA] zinc chloride results in increased expression of SLC2A1 mRNA |
CTD |
PMID:19000923 PMID:22202117 |
|
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Slc30a1 |
solute carrier family 30 member 1 |
multiple interactions increases expression |
ISO EXP |
epigallocatechin gallate inhibits the reaction [zinc chloride results in increased expression of SLC30A1 mRNA]; zinc chloride inhibits the reaction [Grape Seed Proanthocyanidins results in decreased expression of SLC30A1 mRNA] zinc chloride affects the reaction [Cadmium Chloride affects the expression of SLC30A1 mRNA]; zinc chloride promotes the reaction [Glucose results in increased expression of SLC30A1 mRNA] |
CTD |
PMID:18947441 PMID:20392624 PMID:20471814 PMID:23056475 PMID:25653005 PMID:33645215 More...
|
|
NCBI chr13:103,491,037...103,494,910
Ensembl chr13:103,491,037...103,494,910
|
|
G |
Slc30a2 |
solute carrier family 30 member 2 |
increases expression multiple interactions |
EXP |
zinc chloride results in increased expression of SLC30A2 mRNA zinc chloride affects the reaction [Cadmium Chloride affects the expression of SLC30A2 mRNA] |
CTD |
PMID:20392624 PMID:25653005 |
|
NCBI chr 5:146,559,733...146,571,957
Ensembl chr 5:146,559,733...146,571,956
|
|
G |
Slc30a4 |
solute carrier family 30 member 4 |
multiple interactions |
EXP |
zinc chloride affects the reaction [Cadmium Chloride affects the expression of SLC30A4 mRNA] |
CTD |
PMID:25653005 |
|
NCBI chr 3:109,753,270...109,775,306
Ensembl chr 3:109,753,273...109,775,306
|
|
G |
Slc30a5 |
solute carrier family 30 member 5 |
decreases expression multiple interactions |
ISO |
zinc chloride results in decreased expression of SLC30A5 mRNA Dactinomycin inhibits the reaction [zinc chloride results in decreased expression of SLC30A5 mRNA] |
CTD |
PMID:17234632 PMID:20392624 |
|
NCBI chr 2:31,945,745...31,975,969
Ensembl chr 2:31,945,729...31,975,934
|
|
G |
Slc30a7 |
solute carrier family 30 member 7 |
increases expression decreases expression |
ISO |
zinc chloride results in increased expression of SLC30A7 mRNA zinc chloride results in decreased expression of SLC30A7 mRNA |
CTD |
PMID:20392624 |
|
NCBI chr 2:203,855,484...203,922,155
Ensembl chr 2:203,859,175...203,922,132
|
|
G |
Slc31a2 |
solute carrier family 31 member 2 |
increases expression decreases expression |
ISO |
zinc chloride results in increased expression of SLC31A2 mRNA zinc chloride results in decreased expression of SLC31A2 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr 5:75,738,008...75,748,542
Ensembl chr 5:75,738,024...75,748,542
|
|
G |
Slc39a1 |
solute carrier family 39 member 1 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [Grape Seed Proanthocyanidins results in increased expression of SLC39A1 mRNA] |
CTD |
PMID:20471814 |
|
NCBI chr 2:175,703,413...175,709,063
Ensembl chr 2:175,703,441...175,709,058
|
|
G |
Slc39a2 |
solute carrier family 39 member 2 |
multiple interactions increases expression |
ISO |
[SLC39A2 protein co-treated with zinc chloride] results in increased abundance of Glutathione; zinc chloride promotes the reaction [SLC39A2 protein results in increased activity of NFE2L2 protein]; zinc chloride promotes the reaction [SLC39A2 protein results in increased expression of GCLC mRNA]; zinc chloride promotes the reaction [SLC39A2 protein results in increased expression of GCLM mRNA] zinc chloride results in increased expression of SLC39A2 mRNA |
CTD |
PMID:18385089 |
|
NCBI chr15:24,590,738...24,592,850
Ensembl chr15:24,590,738...24,592,850
|
|
G |
Slc39a3 |
solute carrier family 39 member 3 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [Cadmium Chloride results in increased expression of SLC39A3 mRNA] |
CTD |
PMID:25653005 |
|
NCBI chr 7:8,676,845...8,682,846
Ensembl chr 7:8,676,759...8,685,149
|
|
G |
Slc39a4 |
solute carrier family 39 member 4 |
multiple interactions decreases expression |
ISO EXP |
zinc chloride inhibits the reaction [Grape Seed Proanthocyanidins results in increased expression of SLC39A4 mRNA] zinc chloride inhibits the reaction [Cadmium Chloride results in increased expression of SLC39A4 mRNA] zinc chloride results in decreased expression of SLC39A4 mRNA |
CTD |
PMID:20471814 PMID:25653005 |
|
NCBI chr 7:108,333,380...108,337,553
Ensembl chr 7:108,333,381...108,337,553
|
|
G |
Slc39a8 |
solute carrier family 39 member 8 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [Cadmium Chloride results in increased expression of SLC39A8 mRNA] |
CTD |
PMID:25653005 |
|
NCBI chr 2:224,171,787...224,319,326
Ensembl chr 2:224,256,654...224,319,129
|
|
G |
Slc48a1 |
solute carrier family 48 member 1 |
increases expression |
ISO |
zinc chloride results in increased expression of SLC48A1 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 7:128,915,136...128,923,929
Ensembl chr 7:128,915,195...128,923,024
|
|
G |
Slc5a1 |
solute carrier family 5 member 1 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [Cadmium Chloride inhibits the reaction [SP1 protein binds to and affects the expression of SLC5A1 promoter]]; zinc chloride inhibits the reaction [Cadmium Chloride results in decreased expression of SLC5A1 mRNA] |
CTD |
PMID:20060848 |
|
NCBI chr14:77,553,990...77,618,589
Ensembl chr14:77,553,843...77,618,547
|
|
G |
Slc5a2 |
solute carrier family 5 member 2 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [Cadmium Chloride inhibits the reaction [SP110 protein binds to and affects the expression of SLC5A2 promoter]]; zinc chloride inhibits the reaction [Cadmium Chloride results in decreased expression of SLC5A2 mRNA] |
CTD |
PMID:20060848 |
|
NCBI chr 1:182,847,185...182,853,309
Ensembl chr 1:182,847,106...182,853,306
|
|
G |
Slc9a1 |
solute carrier family 9 member A1 |
increases expression |
ISO |
zinc chloride results in increased expression of SLC9A1 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr 5:145,576,341...145,629,630
Ensembl chr 5:145,576,334...145,629,624
|
|
G |
Sord |
sorbitol dehydrogenase |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [Cadmium Chloride results in decreased activity of SORD protein] |
CTD |
PMID:18972399 |
|
NCBI chr 3:109,184,697...109,216,133
Ensembl chr 3:109,184,676...109,216,133
|
|
G |
Sp1 |
Sp1 transcription factor |
multiple interactions increases activity |
ISO |
zinc chloride inhibits the reaction [Cadmium Chloride inhibits the reaction [SP1 protein binds to and affects the expression of SLC5A1 promoter]] zinc chloride results in increased activity of SP1 protein |
CTD |
PMID:9330853 PMID:20060848 |
|
NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:133,541,491...133,571,961
|
|
G |
Sp110 |
SP110 nuclear body protein |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [Cadmium Chloride inhibits the reaction [SP110 protein binds to and affects the expression of SLC5A2 promoter]] |
CTD |
PMID:20060848 |
|
NCBI chr 9:86,200,503...86,225,355
Ensembl chr 9:86,200,503...86,222,670
|
|
G |
Spag4 |
sperm associated antigen 4 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of SPAG4 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 3:144,581,006...144,587,879
Ensembl chr 3:144,581,095...144,585,435
|
|
G |
Spice1 |
spindle and centriole associated protein 1 |
decreases expression |
ISO |
zinc chloride results in decreased expression of SPICE1 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr11:56,289,291...56,332,382
Ensembl chr11:56,290,540...56,332,447
|
|
G |
Spink1 |
serine peptidase inhibitor, Kazal type 1 |
decreases expression |
ISO |
zinc chloride results in decreased expression of SPINK1 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr18:35,870,723...35,882,693
Ensembl chr18:35,824,550...35,882,642
|
|
G |
Spock1 |
sparc/osteonectin, cwcv and kazal like domains proteoglycan 1 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of SPOCK1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr17:6,741,504...7,221,685
Ensembl chr17:6,742,273...7,224,935
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
decreases expression multiple interactions |
ISO |
zinc chloride results in decreased expression of SPP1 mRNA [zinc chloride co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in increased expression of SPP1 mRNA; [zinc chloride deficiency co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in decreased expression of SPP1 mRNA; zinc chloride promotes the reaction [Calcitriol results in increased activity of SPP1 promoter] |
CTD |
PMID:10777672 PMID:19428942 PMID:19913120 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
multiple interactions increases phosphorylation |
EXP |
1,3-dimethylthiourea inhibits the reaction [zinc chloride results in increased phosphorylation of SRC protein]; AG 1879 inhibits the reaction [zinc chloride results in increased phosphorylation of SRC protein]; Vanadates promotes the reaction [zinc chloride results in increased phosphorylation of SRC protein] |
CTD |
PMID:12211081 PMID:21575692 |
|
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
|
|
G |
Srm |
spermidine synthase |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of SRM mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 5:159,025,919...159,029,076
Ensembl chr 5:159,025,873...159,029,405
|
|
G |
Stbd1 |
starch binding domain 1 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of STBD1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr14:15,470,452...15,473,857
Ensembl chr14:15,469,582...15,477,443
|
|
G |
Stmn1 |
stathmin 1 |
increases expression |
ISO |
zinc chloride results in increased expression of STMN1 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154
|
|
G |
Tert |
telomerase reverse transcriptase |
multiple interactions |
ISO |
[Citric Acid co-treated with zinc chloride] results in decreased activity of TERT protein |
CTD |
PMID:16624386 |
|
NCBI chr 1:29,637,213...29,659,509
Ensembl chr 1:29,637,506...29,659,561
|
|
G |
Tf |
transferrin |
multiple interactions increases expression |
ISO |
zinc chloride inhibits the reaction [TF protein results in increased uptake of Iron] zinc chloride results in increased expression of TF mRNA |
CTD |
PMID:11335103 PMID:18947441 |
|
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
|
|
G |
Tfpi2 |
tissue factor pathway inhibitor 2 |
increases expression |
ISO |
zinc chloride results in increased expression of TFPI2 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 4:31,981,786...31,986,707
Ensembl chr 4:31,982,178...31,986,600
|
|
G |
Tfrc |
transferrin receptor |
increases expression |
ISO |
zinc chloride results in increased expression of TFRC mRNA |
CTD |
PMID:19000923 |
|
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
|
|
G |
Tmem45a |
transmembrane protein 45A |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of TMEM45A mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr11:43,713,309...43,799,526
Ensembl chr11:43,713,782...43,799,526
|
|
G |
Tnf |
tumor necrosis factor |
increases expression |
ISO |
zinc chloride results in increased expression of TNF mRNA |
CTD |
PMID:19428942 PMID:21540303 PMID:24284788 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf11b |
TNF receptor superfamily member 11B |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [Cadmium Chloride results in decreased expression of TNFRSF11B protein] |
CTD |
PMID:23726800 |
|
NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:85,566,520...85,594,538
|
|
G |
Tnfsf11 |
TNF superfamily member 11 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [Cadmium Chloride results in increased expression of TNFSF11 protein] |
CTD |
PMID:23726800 |
|
NCBI chr15:53,674,990...53,705,171
Ensembl chr15:53,673,877...53,705,445
|
|
G |
Tnfsf14 |
TNF superfamily member 14 |
multiple interactions |
ISO |
[zinc chloride results in increased abundance of Zinc] which results in increased expression of TNFSF14 mRNA |
CTD |
PMID:31588059 |
|
NCBI chr 9:2,069,075...2,073,128
Ensembl chr 9:2,069,104...2,073,216
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride inhibits the reaction [Doxorubicin results in increased phosphorylation of and results in increased activity of TP53 protein]] |
CTD |
PMID:19714248 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tra2a |
transformer 2 alpha |
decreases expression |
ISO |
zinc chloride results in decreased expression of TRA2A mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 4:78,220,838...78,239,737
Ensembl chr 4:78,220,883...78,239,712
|
|
G |
Tsc22d3 |
TSC22 domain family, member 3 |
multiple interactions |
ISO |
[zinc chloride results in increased abundance of Zinc] inhibits the reaction [Hydrocortisone results in increased expression of TSC22D3 mRNA] |
CTD |
PMID:29957541 |
|
NCBI chr X:104,217,898...104,277,935
Ensembl chr X:104,217,925...104,276,861
|
|
G |
Ttr |
transthyretin |
multiple interactions |
ISO |
[zinc chloride results in increased abundance of Zinc] which results in increased expression of TTR mRNA |
CTD |
PMID:31588059 |
|
NCBI chr18:11,941,791...11,951,008
Ensembl chr18:11,943,789...11,951,008
|
|
G |
Tuba1b |
tubulin, alpha 1B |
increases expression |
ISO |
zinc chloride results in increased expression of TUBA1B mRNA |
CTD |
PMID:18947441 |
|
NCBI chr 7:130,090,669...130,093,644
Ensembl chr 7:130,081,032...130,196,186
|
|
G |
Uba1 |
ubiquitin-like modifier activating enzyme 1 |
multiple interactions |
ISO |
zinc chloride promotes the reaction [Dimethyldithiocarbamate results in decreased activity of and results in decreased ubiquitination of UBA1 protein]; zinc chloride results in decreased activity of and results in decreased ubiquitination of UBA1 protein |
CTD |
PMID:25714994 |
|
NCBI chr X:1,508,700...1,530,677
Ensembl chr X:1,508,666...1,530,636
|
|
G |
Ube2e2 |
ubiquitin-conjugating enzyme E2E 2 |
increases expression |
ISO |
zinc chloride results in increased expression of UBE2E2 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr15:6,980,195...7,257,912
Ensembl chr15:6,980,474...7,257,532
|
|
G |
Unc5b |
unc-5 netrin receptor B |
increases expression |
ISO |
zinc chloride results in increased expression of UNC5B mRNA |
CTD |
PMID:18947441 |
|
NCBI chr20:28,697,726...28,764,474
Ensembl chr20:28,697,726...28,764,537
|
|
G |
Use1 |
unconventional SNARE in the ER 1 |
increases expression |
ISO |
zinc chloride results in increased expression of USE1 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr16:18,038,284...18,041,826
Ensembl chr16:18,039,173...18,041,826
|
|
G |
Utrn |
utrophin |
affects binding |
ISO |
zinc chloride binds to UTRN protein |
CTD |
PMID:17009962 |
|
NCBI chr 1:6,720,854...7,224,313
Ensembl chr 1:6,722,594...7,224,313
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of VEGFA mRNA] zinc chloride inhibits the reaction [Doxorubicin results in increased expression of VEGFA mRNA] |
CTD |
PMID:19714248 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Wdr4 |
WD repeat domain 4 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of WDR4 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr20:9,587,205...9,611,434
Ensembl chr20:9,587,207...9,603,581
|
|
G |
Wsb1 |
WD repeat and SOCS box-containing 1 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of WSB1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr10:64,202,761...64,219,039
Ensembl chr10:64,202,763...64,219,019
|
|
G |
Xcr1 |
X-C motif chemokine receptor 1 |
decreases expression |
ISO |
zinc chloride results in decreased expression of XCR1 mRNA |
| |